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Abstract
RNA degradation is a tightly regulated and highly conserved process which selectively targets aberrant RNAs
using both 5’ and 3’ exonucleases. The RNAs degraded by this process include viral RNA, but the mechanisms
by which viral RNA is identified and recruited to the degradation machinery are incompletely understood. To
identify new antiviral genes, we performed RNAi screening of genes with known roles in RNA metabolism in
Drosophila cells. We identified the RNA exosome, which targets RNA for 3’ end decay, and two components
of the exosome cofactor TRAMP complex, dMtr4 and dZcchc7, as antiviral against a panel of RNA viruses.
As these genes are highly conserved, I extended these studies to human cells and found that the exosome as
well as TRAMP components hMTR4 and hZCCHC7 are antiviral. While hMTR4 and hZCCHC7 are
normally nuclear, I found that infection by cytoplasmic RNA viruses induces their export to cytoplasmic
granules, where they form a complex that specifically recognizes and induces degradation of viral mRNAs.
Furthermore, I found that the 3’ UTR of bunyaviral mRNA is sufficient to confer virus-induced exosomal
degradation, demonstrating cis-regulation.
Several types of ribonucleoprotein (RNP) granules interact with both 5’ and 3’ decay machinery to facilitate
degradation of sequestered RNAs. In order to determine whether TRAMP component-containing granules
contain components of other defined RNP granules, I performed immunofluorescence for hZCCHC7 as well
as components of P-bodies, stress granules, and exosome granules and found that hZCCHC7 can colocalize
with proteins resident in exosome granules and stress granules during viral infection, suggesting that
hZCCHC7 may bind translationally-stalled viral RNAs and bring them to exosome granules for degradation.
To further characterize the regulation of TRAMP component nuclear export during infection, I investigated
the viral signals necessary for this transport. I found that transfection with dsRNA is sufficient to induce
relocalization, while infection with UV-inactivated viruses is not. Moreover, I tested the role of canonical
innate immune adaptors in this process and found that the dsRNA sensor PKR promoted relocalization
during Sindbis virus infection. Altogether, my results reveal that the presence of replicating viral RNA causes
TRAMP components to be repurposed to a cytoplasmic surveillance role in several classes of RNP granules
including stress granules and exosome granules. There, they selectively engage viral RNAs for degradation to
restrict a broad range of viruses.
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ABSTRACT 
A CONSERVED ANTIVIRAL ROLE FOR A VIRUS-INDUCED  
CYTOPLASMIC EXOSOME COMPLEX 
Jerome M Molleston 
Sara Cherry 
 
RNA degradation is a tightly regulated and highly conserved process which selectively targets 
aberrant RNAs using both 5’ and 3’ exonucleases. The RNAs degraded by this process include 
viral RNA, but the mechanisms by which viral RNA is identified and recruited to the degradation 
machinery are incompletely understood. To identify new antiviral genes, we performed RNAi 
screening of genes with known roles in RNA metabolism in Drosophila cells. We identified the 
RNA exosome, which targets RNA for 3’ end decay, and two components of the exosome 
cofactor TRAMP complex, dMtr4 and dZcchc7, as antiviral against a panel of RNA viruses. As 
these genes are highly conserved, I extended these studies to human cells and found that the 
exosome as well as TRAMP components hMTR4 and hZCCHC7 are antiviral. While hMTR4 and 
hZCCHC7 are normally nuclear, I found that infection by cytoplasmic RNA viruses induces their 
export to cytoplasmic granules, where they form a complex that specifically recognizes and 
induces degradation of viral mRNAs. Furthermore, I found that the 3’ UTR of bunyaviral mRNA is 
sufficient to confer virus-induced exosomal degradation, demonstrating cis-regulation.  
Several types of ribonucleoprotein (RNP) granules interact with both 5’ and 3’ decay machinery to 
facilitate degradation of sequestered RNAs. In order to determine whether TRAMP component-
containing granules contain components of other defined RNP granules, I performed 
immunofluorescence for hZCCHC7 as well as components of P-bodies, stress granules, and 
exosome granules and found that hZCCHC7 can colocalize with proteins resident in exosome 
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granules and stress granules during viral infection, suggesting that hZCCHC7 may bind 
translationally-stalled viral RNAs and bring them to exosome granules for degradation. 
To further characterize the regulation of TRAMP component nuclear export during infection, I 
investigated the viral signals necessary for this transport. I found that transfection with dsRNA is 
sufficient to induce relocalization, while infection with UV-inactivated viruses is not. Moreover, I 
tested the role of canonical innate immune adaptors in this process and found that the dsRNA 
sensor PKR promoted relocalization during Sindbis virus infection. Altogether, my results reveal 
that the presence of replicating viral RNA causes TRAMP components to be repurposed to a 
cytoplasmic surveillance role in several classes of RNP granules including stress granules and 
exosome granules. There, they selectively engage viral RNAs for degradation to restrict a broad 
range of viruses. 
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I. INTRODUCTION 
RNA decay 
While much of RNA biology focuses on regulation of RNA transcription, RNA decay is also tightly 
regulated. Controlled RNA degradation is essential for maturation of complex RNAs, degradation 
of misprocessed RNAs, and rapid downregulation of cohorts of RNAs in response to particular 
stimuli. Partial degradation of RNAs is an important part of processing; a plethora of RNAs, 
including rRNAs, snRNAs, and snoRNAs, must be trimmed to their mature forms (Allmang et al. 
1999a). Additionally, RNA degradation acts as a quality control measure to prevent aberrant 
species of RNA from building up and occupying or disabling either the translational machinery or 
other RNA-binding proteins. Moreover, RNAs which fail to be properly matured, such as 
hypoadenylated mRNAs and hypomodified tRNAs, are degraded before they can leave the 
nucleus (Kadaba 2004; Milligan et al. 2005). Additional checkpoints such as nonsense-mediated 
decay or no-go decay detect stalled ribosomes or premature stop codons and degrade the 
aberrant mRNA messages that caused these problems in order to release the translational 
machinery (Isken and Maquat 2007). More recent studies have shown that RNA decay also 
serves a key role in post-transcriptional regulation of groups of RNAs, known as regulons, which 
are rapidly co-regulated through specific recognition of sequences in their 5’ and 3’ UTRs such as 
AU-rich elements (AREs) (Keene 2007). 
5’ decapping and decay 
RNA decay is largely dependent on exonucleases and can proceed from either the 5’ or 3’ end of 
an RNA transcript. Messenger RNAs targeted for decay are first deadenylated by the CCR4-NOT 
complex, often assisted by other deadenylating enzymes, before they can be degraded (Lejeune 
et al. 2003; Parker and Sheth 2007). Though deadenylation is the first and rate-limiting step in 
mRNA degradation, it is sometimes reversible, and can act to “pause” translation of mRNAs 
rather than degrading them (Huarte et al. 1992). Removal of the 5’ cap of RNA by decappers 
such as Dcp2 is irreversible, and permits degradation by the 5’ to 3’ exonuclease Xrn1 (Hsu and 
Stevens 1993; Muhlrad et al. 1994). This process is largely conserved from yeast to mammals, 
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though mammals have developed multiple partially redundant decapping enzymes for different 
degradation methods; Dcp2 is preferentially utilized in nonsense-mediated decay, while Nudt16 is 
preferentially involved in degradation of mRNAs containing AREs or 5’ terminal oligopyrimidines  
(Li et al. 2011; Hopkins et al. 2015).  
P-bodies 
Deadenylation, decapping, and 5’ degradation activities are especially concentrated at 
ribonucleoprotein (RNP) structures called processing bodies (P-bodies). These structures consist 
primarily of deadenylated mRNAs targeted for decay as well as components of the decapping 
and 5’ degradation machinery, including Dcp2, its activators, and Xrn1 (Sheth and Parker 2003; 
Parker and Sheth 2007). RNAs sent to P-bodies are removed from translation, and can either be 
degraded or subsequently returned to the active pool of mRNAs (Brengues et al. 2005). Though 
P-bodies are present in normal cells at baseline, their number and size increase in response to a 
variety of stressors such as cold-shock or arsenic treatment (Kedersha et al. 2005; Ayache et al. 
2015). They can interact and exchange RNAs with other RNP granules such as stress granules, 
which are composed of translationally-stalled RNAs and chaperone proteins (Kedersha et al. 
2005; Wilczynska et al. 2005). There is evidence that P-bodies are a consequence of high 
concentrations of mRNAs undergoing decay rather than being necessary for decay; P-body 
integrity is RNA-dependent, and P-body structure can be disrupted without preventing RNA 
degradation (Teixeira et al. 2005; Eulalio et al. 2007). Furthermore, upregulation of 5’ decapping 
and decay can prevent formation of the P-body RNP structure by depleting RNA targets (Hopkins 
et al. 2015). 
The 3’ to 5’ RNA exosome 
Many RNA decay roles also employ 3’ to 5’ degradation, mediated by the RNA exosome 
complex. The exosome is a barrel-like complex consisting of a hexameric structure (6 proteins 
with RNase PH homology) and a cap structure (3 proteins with S1 RNA-binding domains) 
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(Raijmakers et al. 2002; Liu et al. 2006; Schneider and Tollervey 2013). These structural 
components of the exosome form an internal channel wide enough to permit entry of single-
stranded but not double-stranded RNA (Makino et al. 2013). Exosome proteins share structural 
and sequence homology to RNases; however, the structural components of the exosome are not 
believed to contribute directly to RNA degradation in vivo. Rather, in yeast where it has been 
highly characterized, the 3’ to 5’ exonuclease activity is performed by two exosome-associated 
RNA exonucleases: Rrp6, which is exclusive to the nucleus, and Dis3, which is present in both 
the nucleus and the cytoplasm (Mitchell et al. 1997; Allmang et al. 1999b; Dziembowski et al. 
2007).  
The exosome is both structurally and functionally conserved from yeast to humans (Houseley and 
Tollervey 2009). As such, mutations in the yeast exosomal genes Rrp4, Csl4, or Dis3 can be 
complemented with the human orthologs to rescue function (Allmang et al. 1999b). Despite this 
conservation, the localization of the exosome exonucleases has diverged over evolutionary 
history. Rrp6 is present in both the nuclear and cytoplasmic fractions of human cells, and Dis3 
has two additional paralogs in humans, Dis3L1 and Dis3L2, which function exclusively in the 
cytoplasm (Tomecki et al. 2010). Dis3L2, which lacks the exosome-associating PIN domain, 
operates independently of the larger exosome complex in a separate 3’ to 5’ degradation system 
which favors terminally uridylated RNAs (Chang et al. 2013; Ustianenko et al. 2013; Thomas et 
al. 2015). 
Exosome cofactor complexes 
Though the exosome degrades RNAs indiscriminately in vitro, it degrades RNAs in vivo in a 
regulated fashion using RNA-binding cofactor complexes (Houseley et al. 2006). All known 
exosome cofactor complexes are anchored by helicases. The definitive role of these helicases is 
unknown, but it is hypothesized that they unwind higher-order structures to permit single-stranded 
RNA to be inserted into the exosome (de la Cruz et al. 1998). The exosome targets different 
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RNAs for processing and degradation in the nucleus, nucleolus, and cytoplasm, and thus relies 
on different cofactors in each subcellular compartment to target RNAs for degradation (Figure 1). 
Two major complexes, the cytoplasmic Ski and nuclear TRAMP complexes, have been 
extensively characterized in yeast. 
The Ski complex 
The Superkiller (Ski) complex is the major cytoplasmic exosome cofactor complex in yeast, 
named for the “superkilling” phenotype of dsRNA viruses, which are lethal to yeast deficient in 
these genes (Toh-E et al. 1978). The Ski genes were identified before the discovery of the 
exosome, and though mutants in Ski genes lead to increased viral RNA, this has not yet been 
definitively linked to exosomal RNA degradation (Masison et al. 1995). The Ski complex consists 
of a DExH/D-box helicase, Ski2, a tetratricopeptide repeat-containing protein, Ski3, and a WD 
repeat-containing protein, Ski8 (Brown et al. 2000). It also uses the adaptor G-protein Ski7 to 
interact with the exosome (Araki et al. 2001). In addition to affecting the half-life of normal 
mRNAs, the Ski complex is involved in recruiting the exosome to RNAs targeted for nonsense-
mediated decay as well as nonstop decay (Jacobs Anderson and Parker 1998; van Hoof et al. 
2002; Horikawa et al. 2016). Orthologs for all three Ski genes are present in higher organisms 
including Drosophila and humans and have RNA decay roles, though their specific targets remain 
unclear (Orban and Izaurralde 2005; Zhu et al. 2005). 
The TRAMP complex 
The yeast TRAMP (Trf4/5-Air1/2-Mtr4-Polyadenylation) complex, located in the nucleus, has 
known roles in degrading hypomodified tRNAs, hypoadenylated mRNAs, and in the processing of 
normal rRNA, snRNA, and snoRNA during maturation (Kadaba 2004; LaCava et al. 2005; 
Milligan et al. 2005; Wyers et al. 2005; Houseley et al. 2006). The complex is anchored by a 
DExD/H box helicase, Mtr4, which binds the other TRAMP components through its arch domain 
(de la Cruz et al. 1998; Jackson et al. 2010). The Zn-knuckle RNA-binding proteins Air1 and Air2 
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are believed to convey RNA-binding specificity to the complex, identifying specific targets for 
degradation (Schmidt et al. 2012). These two proteins are partially functionally redundant; 
mutants in each protein accumulate different but overlapping populations of snRNAs, snoRNAs, 
and mRNAs, and double-mutant strains fail to grow. Trf4 and Trf5 are non-canonical poly(A) 
polymerases which add 5-6 adenines to RNAs bound to the TRAMP complex (LaCava et al. 
2005). The addition of short poly(A) tails creates an unstructured 3’ end which is thought to 
facilitate insertion of the RNA into the exosome barrel (Paolo et al. 2009). Furthermore, this 
adenylation parallels the role of polyadenylation in E. coli, which, unlike eukaryotic 
polyadenylation, targets RNAs for decay (Li et al. 2002; Deutscher 2006). In addition to the 
canonical TRAMP complex, Mtr4 can form other modular cofactor complexes by associating with 
the adaptors Nop53 or Utp18, which assist in some rRNA maturation steps (Thoms et al. 2015). 
The TRAMP complex is conserved in humans, but nuclear RNA degradation has additional 
complexity. As in yeast, human TRAMP is composed of a helicase, hMTR4, a zinc-finger Air-like 
protein, hZCCHC7, and a poly(A) polymerase, hTRF4-1 or hTRF4-2 (Fasken et al. 2011; Lubas 
et al. 2011). However, unlike yeast TRAMP, the human TRAMP complex is restricted to the 
nucleolus, and is only known to process rRNA (Shcherbik et al. 2010; Lubas et al. 2011). Most of 
the yeast TRAMP targets, such as mRNAs, snRNAs, snoRNAs, and promoter upstream 
transcripts (PROMTs) appear to be regulated in human cells by the nucleoplasmic NEXT 
(Nuclear EXosome Targeting) complex, which shares hMTR4 with the TRAMP complex but also 
contains the zinc-finger protein hZCCHC8 and the RNA-binding motif protein RBM7 (Lubas et al. 
2011; Andersen et al. 2013; Lubas et al. 2015). Other targets are likely to exist for mammalian 
TRAMP-like complexes; murine cells depleted of Mtr4 accumulate adenylated 5’ miRNA 
fragments, suggesting that adenylation and Mtr4-mediated degradation may be important for 
these RNAs (Dorweiler et al. 2014). The full spectrum of Mtr4-anchored complexes in mammals 
and the regulation of other classical yeast TRAMP targets (such as misprocessed tRNAs) remain 
unclear. 
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Exosome cofactor localization 
The localization of exosome core and cofactor components in yeast is generally used as a basis 
for understanding exosomal regulation in different cellular compartments across species. 
However, the localization of exosome cofactors is poorly conserved between species. For 
example, while Rrp6 is exclusively nuclear in yeast, it localizes to both the nucleus and cytoplasm 
in human cells (Allmang et al. 1999b; Tomecki et al. 2010). Furthermore, though the yeast Ski 
complex is restricted to the cytoplasm, the human Ski complex components Ski2 and Ski8 both 
localize to the nucleus as well as the cytoplasm and associate with transcriptionally active genes 
(Brown et al. 2000; Zhu et al. 2005). Even within fungi, yeast Mtr4 is exclusively nuclear, while in 
the mold Neurospora, Mtr4 also localizes to the cytoplasm, where it functions in regulating 
circadian rhythms as well as maturation of microRNA-like RNAs (Guo et al. 2009; Xue et al. 
2012). Thus, it is likely that there is more complexity in the regulation of the exosome and its 
cofactors outside of their canonical roles. 
Viral RNAs as degradation targets 
Cellular RNAs targeted for degradation have sequences or structures that make them susceptible 
to recognition by the RNA degradation machinery, such as missing 5’ caps or poly(A) tails, or 
regulatory sequences in the 5’ or 3’ UTRs. Similarly, the RNAs produced by RNA viruses can 
differ substantially from normal cellular RNAs, leading to recognition by host RNA-binding 
proteins. RNA viruses encode an RNA-dependent RNA polymerase (RdRp) which replicates RNA 
through the generation of antigenome intermediates. This creates transient dsRNA structures and 
5’ triphosphate ends not usually present in cellular mRNAs (Moon and Wilusz 2013). 
Furthermore, cytoplasmic RNA viruses are isolated from the normal cellular capping machinery, 
and thus the RdRp or associated viral proteins must generate a cap or cap mimic, or acquire one 
from cellular mRNA through a process known as cap-snatching (Decroly et al. 2012). Additionally, 
viral RNAs must protect their 3’ ends, either through RdRp-mediated polyadenylation or through 
3’ structures which impede exonucleases (Moon et al. 2012b). Protective 3’ structures act either 
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by recruiting protective proteins like poly(A) binding protein, or by directly inhibiting exonuclease 
progression (Ford and Wilusz 1999; Iwakawa et al. 2012). All of this must be done with limited 
protein machinery, as RNA virus genomes are generally small.  
Innate immune recognition of viral RNA 
RIG-I like receptors 
The RNAs produced during viral replication serve as an important sign of infection in mammalian 
cells. Cytosolic viral RNAs are primarily recognized by the RIG-I-like receptors (RLRs), RIG-I and 
MDA-5, which are both DExD/H-box RNA helicases (Barbalat et al. 2011). Each recognizes 
different foreign RNA structures. RIG-I recognizes short dsRNAs and RNAs with 5’ triphosphates, 
and has roles in restricting viruses such as paramyxoviruses, orthomyxoviruses, and flaviviruses 
(Hornung et al. 2006; Kato et al. 2006). Meanwhile, MDA-5 recognizes longer dsRNAs and 
higher-order RNA structures, and is integral for recognition of picornaviruses (Gitlin et al. 2006; 
Pichlmair et al. 2009). Both are able to respond to the synthetic dsRNA polyinosinic-polycytidylic 
acid (poly(I:C)) dependent on length; long poly(I:C) is a traditional ligand of MDA-5, while 
shortened poly(I:C) can activate RIG-I (Kato et al. 2008). The RLRs primarily act by signaling the 
interferon system through their adaptor, MAVS; interferon in turn signals a variety of antiviral 
programs (Kawai et al. 2005; Meylan et al. 2005; Seth et al. 2005; Xu et al. 2005). Diverse RNA 
viruses are able to evade the interferon system and thus avoid the consequences of RLR 
detection; for example, both Rift Valley fever virus (RVFV) and Sindbis virus (SINV) make 
accessory proteins (NSs and nsP2) which inhibit the transcription of interferon genes (Bouloy et 
al. 2001; Frolova et al. 2002; Billecocq et al. 2004; Gorchakov et al. 2004; Garmashova et al. 
2006). 
Toll-like receptors 
Endosomal RNAs are sensed by TLR3 and TLR7, which detect dsRNA and ssRNA respectively, 
and signal interferon through the adaptors TRIF and MyD88 (Barbalat et al. 2011). Many cell 
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culture systems such as the U2OS osteosarcoma cells used in this dissertation lack cell surface 
TLR’s such as TLR3 and can only effectively sense cytosolic RNA (Laredj and Beard 2011).  
PKR 
Mammalian cells possess several other sensors of viral RNA. Within the cytoplasm, the dsRNA-
activated protein kinase PKR is upregulated by interferon signaling (Clemens et al. 1993; Gale 
and Katze 1998). Activation of PKR by dsRNAs from viruses or poly(I:C) induces 
autophosphorylation of PKR and subsequent phosphorylation of eIF2α, shutting down protein 
translation in order to block synthesis of viral proteins (Meurs et al. 1990; Hinnebusch 1994; 
Balachandran et al. 2000; Chacko and Adamo 2011). Several viral methods to avoid PKR-
mediated translational shutdown exist in different virus species; RVFV infection causes PKR 
degradation, and the SINV genome, despite activating PKR, has internal sequences which allow 
viral proteins to be translated efficiently despite widespread host translational shutdown 
(Gorchakov et al. 2004; Ikegami et al. 2009; Kainulainen et al. 2016). PKR may also have 
additional phosphorylation targets which are yet to be discovered. Several studies of viruses such 
as vaccinia and rotavirus have found that some MAVS-mediated signaling requires PKR and 
vice-versa, suggesting that the two cytosolic viral RNA sensor pathways have some crosstalk 
(Zhang et al. 2009; Sen et al. 2011). 
OAS and RNASEL 
Part of the interferon-induced antiviral response targets viral RNA for degradation. Another 
cytoplasmic sensor of viral dsRNA, oligoadenylate synthetase (OAS), is upregulated by treatment 
with interferon (Hovanessian et al. 1987; Jensen and Thomsen 2012). Upon sensing viral RNA, 
OAS synthesizes 2,5-adenylate, which in turn serves as an activator of RNASEL, a cytoplasmic 
RNase. RNASEL indiscriminately cleaves viral RNA and cellular RNA, creating an antiviral and 
pre-apoptotic pathway (Castelli et al. 1997). Recent studies have begun to characterize RNAs as 
more or less susceptible to RNASEL and to further postulate functions for RNASEL-mediated 
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regulation of RNAs. Regardless, RNASEL broadly cleaves cellular RNAs and thus serves as a 
precursor to cell death rather than as a targeted antiviral response (Brennan-Laun et al. 2014). 
Antiviral roles for the RNA silencing machinery 
Just as mammalian cells utilize RNA helicases (the RLRs) to recognize cytosolic viral RNA, the 
closest Drosophila homolog, Dicer-2, recognizes the dsRNA intermediates generated during viral 
infection (Lee et al. 2004; Galiana-Arnoux et al. 2006; Takeuchi and Akira 2008). Dicer-2 
functions as both sensor and effector; in addition to its helicase domain, it has an RNase III 
domain which cleaves dsRNAs into siRNAs, which in turn are loaded into the Argonaute 2-
containing RISC (RNA-induced silencing complex), preventing RNA transcription and cleaving 
viral RNAs (Wang et al. 2006). The antiviral RNA silencing pathway in Drosophila is essential to 
immunity; flies with mutations in this pathway succumb to viral infection much more rapidly. In 
turn, natural Drosophila pathogens such as Drosophila C virus encode suppressors of RNAi to 
evade this type of degradation (Galiana-Arnoux et al. 2006; van Rij et al. 2006). Dicer-2 likely has 
silencing-independent antiviral functions as well which may more closely parallel the signaling 
functions of the RLRs; recent evidence shows that Dicer-2 induces transcription of the antiviral 
factor Vago in addition to its role in silencing, suggesting that it is a regulator of antiviral 
transcription during viral infection in fly cells (Deddouche et al. 2008). 
RNA silencing has not yet been clearly demonstrated as a biologically relevant antiviral pathway 
in mammalian cells; mammalian Dicer is functionally orthologous to Drosophila Dicer-1 rather 
than Dicer-2, and thus primarily processes pre-miRNAs rather than viral dsRNAs (Lee et al. 
2004). However, recent work has suggested that under some conditions mammalian cells can 
use components of the silencing machinery to degrade viral RNA. Murine embryonic stem cells 
have been shown to make Dicer-dependent siRNAs in response to several RNA viruses (Maillard 
et al. 2013). Infection of murine fibroblasts with SINV containing a pri-miRNA sequence results in 
the formation of mature miRNAs which restrict replication of the virus (Shapiro et al. 2010). 
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Finally, Drosha, a nuclear RNase III enzyme which has a canonical role in processing pri-miRNAs 
to pre-miRNAs before they are exported to the cytoplasm for Dicer processing, has recently been 
identified as an antiviral factor (Shapiro et al. 2014). Drosha is exported to the cytoplasm in 
response to infection with a variety of RNA viruses, and is capable of cleaving viral RNA in the 
cytoplasm to restrict replication. 
Antiviral roles for 5’ to 3’ RNA decay 
Several RNA decay pathways are emerging as antiviral and can target viruses that antagonize 
classical innate immune RNA recognition pathways. The 5’ to 3’ RNA decay machinery can inhibit 
viral replication in a number of different ways (Figure 2). Studies have shown that the cytoplasmic 
5’ RNA exonuclease, Xrn1, can target flavivirus RNAs and in response these viruses antagonize 
Xrn1 by encoding structured RNAs that result in Xrn1 stalling (Jones et al. 2010; Silva et al. 2010; 
Moon et al. 2012a). Furthermore, poliovirus induces the degradation of host 5’ decay factors such 
as Xrn1 and Dcp2 through a combination of viral and host proteases, suggesting evolutionary 
pressure to evade host 5’ RNA decay machinery (Dougherty et al. 2011). In addition to directly 
targeting viral RNAs, the 5’ decay machinery can also impact viral replication indirectly. Recent 
studies showed that decappers limit the pool of host mRNAs available for RVFV to cap snatch 
from, attenuating replication in both insects and mammals (Hopkins et al. 2013; Hopkins et al. 
2015). Furthermore, in mammals, RVFV infection induces NUDT16-mediated decapping and 
decay of 5’ TOP-containing mRNAs encoding the translational machinery, limiting both global and 
virus-specific translation (Hopkins et al. 2015). 
In addition, P-body structure is disturbed during infection with a number of viruses. This can be 
due to an increase in RNA decay; the upregulation of 5’ decay in RVFV infection prevents the 
formation of P-bodies due to depletion of the RNA targets around which they nucleate (Hopkins et 
al. 2015). In contrast, poliovirus induces the degradation of 5’ decay proteins such as Xrn1 and 
Dcp1a, preventing P-body formation (Dougherty et al. 2011). Amazingly, P-body components can 
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be repurposed by viruses to facilitate infection; flaviviruses relocalize P-body components to viral 
replication centers, where they bind viral 3’ UTRs and are necessary for efficient viral replication 
(Emara and Brinton 2007; Ward et al. 2011; Chahar et al. 2013). 
Antiviral roles for the RNA exosome 
Studies have implicated the 3’-5’ exosome in antiviral defense in several contexts. A number of 
antiviral RNA-binding proteins co-immunoprecipitate with the exosome, suggesting that their 
mechanism of action may involve exosomal degradation (Figure 2). DDX17 restricts RVFV by 
binding a miRNA-like stem loop structure encoded in the viral RNA (Moy et al. 2014a). Though its 
mechanism of restriction is unknown, DDX17 binds to exosomal proteins, suggesting the 
possibility that it directly recruits the exosome to degrade viral RNA (Chen et al. 2008; Lubas et 
al. 2011). DDX60, which is antiviral against vesicular stomatitis virus (VSV), also binds the 
exosome (Miyashita et al. 2011). However, DDX60 does not depend on the exosome for its 
antiviral function, but rather bridges viral RNA and the RLRs to potentiate signaling. The cytidine 
deaminase AID, which binds the exosome and hepatitis B virus (HBV) RNA in a complex, is 
antiviral when overexpressed only if the exosome is present, suggesting the possibility that it 
recruits the exosome to degrade HBV RNA (Liang et al. 2015). The zinc-finger antiviral protein 
(ZAP) binds SINV and retrovirus RNA as well as components of the exosome (Guo et al. 2004). 
In overexpression systems, ZAP restricts MLV viral replication in an exosome-dependent fashion, 
as well as affecting the expression and stability of viral luciferase reporters for both MLV and HIV 
(Guo et al. 2007; Zhu et al. 2011). It remains unclear if the exosome is required for the activity of 
endogenous ZAP or degrades ZAP-bound viral RNAs. The cell biology of these factors is largely 
unexplored but overexpressed DDX60 and ZAP localize to the cytoplasm, while overexpressed 
AID binds the exosome in both the nucleus and cytoplasm (Liu et al. 2004; Miyashita et al. 2011; 
Liang et al. 2015). DDX17 moves from the nucleus to the cytoplasm in response to viral infection 
(Moy et al. 2014a). 
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One final role was demonstrated for the exosome cofactor Ski complex in immunity, though this 
role was in preventing autoimmunity rather than restricting viral replication. The human Ski 
helicase SKI2L was found to degrade extraneous RIG-I targets in uninfected cells, protecting 
cells from autoimmune activation (Eckard et al. 2014). Furthermore, patients with mutations in 
this gene were identified and had anomalously high interferon signatures. Though no core 
exosome components or exonucleases were shown in this role, it does suggest that the Ski 
complex, potentially with the exosome, may serve to protect the intracellular milieu from 
overactive RIG-I signaling, paralleling the role of the DNA exonuclease TREX, which degrades 
cytoplasmic DNA to prevent overactivation of the DNA sensor cGAS (Stetson et al. 2008; Crow 
and Rehwinkel 2009; Cai et al. 2014).   
The arthropod-borne viruses 
Arthropod-borne viruses (arboviruses) are transmitted from arthropod hosts such as mosquitos to 
vertebrates such as humans (Weaver and Barrett 2004). All arboviruses that infect humans are 
RNA viruses, and belong to the Alphaviridae, Flaviviridae, or Bunyaviridae families, though 
members of other virus families such as Rhabdoviridae can be transmitted to other animals from 
arthropods (Weaver and Reisen 2010). Both alphaviruses and flaviviruses are positive-sense 
RNA viruses, and thus have a genome which functions as an mRNA. In contrast, bunyaviruses 
and rhabdoviruses are negative-sense RNA viruses which must bring the RdRp within the viral 
particle in order to synthesize positive-sense mRNA from the genome (Tao and Ye 2010). Three 
viruses were used in this dissertation: vesicular stomatitis virus, Sindbis virus, and Rift Valley 
fever virus. 
Vesicular stomatitis virus 
Vesicular stomatitis virus (VSV) is a negative-sense rhabdovirus transmitted to cattle from biting 
flies (Letchworth et al. 1999). It is an important model virus, serving as the prototype for more 
deadly rhabdoviruses such as rabies virus. It has a single 5’ triphosphorylated genomic RNA 
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which is tightly encapsidated by the nucleocapsid protein. The mRNAs, N, M, G, P, and L, are 
synthesized by the RdRp through a start-stop mechanism which results in a capped and 
polyadenylated mRNA for each gene (Schnell et al. 1996). The RdRp synthesizes a 5’ cap at the 
beginning of each mRNA, and polyadenylates by “slipping” during transcription of a U-rich track at 
the end of each mRNA (Schubert et al. 1980; Koonin and Moss 2010). 
Sindbis virus 
Sindbis virus (SINV) is a positive-sense alphavirus transmitted to humans by mosquitos, causing 
a mild febrile illness (Strauss and Strauss 1994). It serves as the prototype for emerging 
alphaviruses including chikungunya virus. SINV has a single genomic RNA which is capped and 
polyadenylated and serves as an mRNA for the nonstructural polyprotein, which is cleaved into 
several functional proteins. During replication it synthesizes a negative-sense antigenome as well 
as a positive-sense subgenomic mRNA expressing only the structural proteins. The SINV 
replicase complex synthesizes a 5’ cap for both the genomic and subgenomic RNAs. Though 
SINV RNAs are covered by a nucleocapsid in the virion, they are not protected from RNAses in 
vitro, making them accessible by RNA decay machinery in vivo (Coombs et al. 1984). This is 
consistent with the fact that the genomic and subgenomic RNAs serve as messenger RNAs and 
thus require access to the host translational machinery. To counter this vulnerability, SINV mRNA 
has evolved sequences in its 3’ UTR which protect it from host deadenylation (Garneau et al. 
2008). 
Rift Valley fever virus 
Rift Valley fever virus (RVFV) is a bunyavirus, a negative-sense trisegmented RNA virus which is 
transmitted to humans by mosquitos (Bird et al. 2009). It causes Rift Valley fever, which results in 
flu-like symptoms in humans with occasional severe complications such as hepatitis or retinitis. It 
is of particular concern agriculturally, as RVFV causes abortion and juvenile death in livestock 
populations. RVFV has three RNA segments of different sizes. The large segment contains the 
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polymerase gene (L), the medium segment encodes a polyprotein which is processed into two 
glycoproteins (Gn and Gc) and a nonstructural protein (NSm), and the small segment encodes 
nucleocapsid (N) as well as a nonstructural protein (NSs). The small segment is unique in that the 
NSs gene is transcribed from the antigenome rather than the genome, making this RNA segment 
ambisense (Bouloy and Weber 2010). N and NSs mRNAs are non-overlapping, and each is 
significantly shorter than the genomic and antigenomic small segment RNA. Though the genomic 
and antigenomic RNAs are not capped or adenylated, they are tightly encapsidated by 
nucleocapsid protein which protects them from RNases in vitro (Kolakofsky and Hacker 1991). 
Synthesis of RVFV mRNAs involves cytoplasmic cap-snatching of host mRNAs targeted for 
degradation, and thus mRNAs possess a natural 5’ cap and 12-18 nt of host mRNA sequence 
(Patterson et al. 1984; Reguera et al. 2010; Hopkins et al. 2013; Hopkins et al. 2015). However, 
these mRNAs are not polyadenylated; each mRNA has a different 3’ UTR, which are 
hypothesized to be protected by stem-loop structures (Ikegami et al. 2007). How these mRNAs 
are translated without polyadenylation is not yet well understood. 
Aims of present studies 
The work of this dissertation arises from the identification of several exosome genes as antiviral 
from Drosophila RNAi screens in VSV, SINV, and RVFV. In chapter 2, I demonstrate a broadly 
antiviral role for the exosome and two components of the TRAMP cofactor complex, Mtr4 and 
Zcchc7. I found that this antiviral role is conserved from flies to human cells, and involves the 
export of basally nucleolar TRAMP components to the cytoplasm upon cellular sensing of viral 
infection. These components accumulate in cytoplasmic granules in infected cells, and 
immunoprecipitate with each other, the RNA exosome, and viral mRNA. I found that the exosome 
regulates RVFV mRNA stability specifically through recognition of sequences in the 3’ UTR. In 
chapter 3, I explore the cellular sensing that leads to TRAMP component relocalization during 
SINV infection. I show that sensing of viral RNA rather than viral protein triggers TRAMP export, 
and that this export is dependent on PKR. Previous work has shown that SINV viral replication 
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can induce the formation of RNP granules such as stress granules (Onomoto et al. 2012). I 
demonstrate here that the cytoplasmic TRAMP punctae can colocalize with stress granule and 
exosome granule markers. I suggest that TRAMP identifies translationally-stalled viral RNA 
targets in stress granules and brings them to exosome granules for decay, linking these two types 
of RNP granule. Together, my dissertation work characterizes a new antiviral role for the 
exosome and two TRAMP cofactors, as well as a new mechanism that regulates viral RNA 
decay. 
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Figure 1: The cofactor complexes of the human RNA exosome. 3’-5’ RNA exosome degrades 
diverse RNA species in different subcellular compartments and thus relies on different cofactor 
complexes to identify RNA targets in the cytoplasm, nucleus, and nucleolus. Each complex is 
anchored by a helicase (Ski2 in the cytoplasm, Mtr4 in the nucleus and nucleolus) and uses other 
RNA-binding proteins to identify specific RNA targets for degradation. These are the complexes 
in humans and other higher animals; in yeast, TRAMP is the sole nuclear cofactor complex and 
performs the roles of human TRAMP and NEXT.  
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Figure 2: Both 5’ and 3’ decay machinery restrict virus infection. The 5’ to 3’ decay 
machinery can inhibit viral infection directly through degradation of viral RNA (flaviviruses) or 
indirectly through decapping and degradation of RNAs needed for viral transcription and 
translation (bunyaviruses). The 3’ to 5’ decay machinery, the RNA exosome, interacts with a 
variety of RNA-binding proteins, some of which are exported to the cytoplasm in response to viral 
infection. Recruitment of the exosome can result in degradation of viral RNA. 
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II. A CONSERVED VIRUS-INDUCED CYTOPLASMIC TRAMP-LIKE COMPLEX 
RECRUITS THE EXOSOME TO TARGET VIRAL RNA FOR DEGRADATION 1 
Background 
RNA decay is tightly regulated to ensure cellular homeostasis. This requires specific recognition 
and targeting by RNA exonucleases (Garneau et al. 2007). The 5’ RNA degradation machinery 
utilizes decapping enzymes to remove the 5’ cap, allowing 5’ to 3’ exonucleases to degrade 
target RNA (Hsu and Stevens 1993; Muhlrad et al. 1994). Degradation from the 3’ end is largely 
mediated by the RNA exosome, a highly conserved multisubunit complex generally consisting of 
9 core factors that form a barrel structure (Schneider and Tollervey 2013).  RNAs are inserted 
into this barrel and subsequently degraded by the two associated 3’ to 5’ exonucleases, Rrp6 and 
Dis3. Exosomal degradation has roles in normal RNA biogenesis and turnover as well as 
surveillance of aberrant RNAs including misfolded or mismodified tRNAs and mRNAs with 
defective polyadenylation (Allmang et al. 1999a; Kadaba 2004; Milligan et al. 2005). The 
exosome has also been implicated in regulation of RNA regulons, functionally related sets of 
mRNAs which are tightly co-regulated through common sequences in their 3’ UTRs (Chen et al. 
2001; Mukherjee et al. 2002; Keene 2007; Singer et al. 2012; Blackinton and Keene 2014). 
Specificity for exosomal degradation is provided by RNA-binding cofactor complexes anchored by 
DExD/H-box helicases that directly associate with the target RNA and the exosome, inserting 
these RNAs for decay (Houseley and Tollervey 2009). The best-characterized cofactors are the 
yeast TRAMP (Trf4/5-Air1/2-Mtr4-Polyadenylation) and Ski (Superkiller) complexes, which have 
known roles in the nucleus and cytoplasm, respectively (Brown et al. 2000; LaCava et al. 2005; 
                                                     
1 This chapter is reprinted from Molleston JM, Sabin LR, Moy RH, Menghani SV, Rausch K, 
Gordesky-Gold B, Hopkins KC, Zhou R, Jensen TH, Wilusz JE, and Cherry S. 2016. A conserved 
virus-induced cytoplasmic TRAMP-like complex recruits the exosome to target viral RNA for 
degradation. Genes & Development 30: 1658-1670. With permission from Cold Spring Harbor 
Laboratory Press. 
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Vanácová et al. 2005; Wyers et al. 2005). In yeast, the TRAMP complex facilitates nuclear 
surveillance of improperly processed mRNAs, rRNAs, snRNAs, snoRNAs, and tRNAs, while the 
Ski complex is involved in mRNA turnover, nonsense-mediated decay, and nonstop decay 
(Anderson and Parker 1998; Kadaba 2004; Milligan et al. 2005; Wyers et al. 2005; Houseley et al. 
2006). In human cells, the nuclear surveillance roles are only beginning to be elucidated, but 
appear to be further subdivided into two Mtr4-anchored complexes: human TRAMP is restricted 
to the nucleolus and engages rRNA precursors, while the NEXT (Nuclear Exosome Targeting) 
complex, which is restricted to the nucleoplasm, binds mRNAs, snRNAs, snoRNAs, and promoter 
upstream transcripts (PROMPTs) (Lubas et al. 2011; Andersen et al. 2013; Lubas et al. 2015). 
The full spectrum of RNA targets of these cofactor complexes and the exosome remains 
unknown.  
Viral RNAs, much like aberrant cellular transcripts, differ from normal RNAs. These differences 
can include the presence of double stranded RNA structures, 5’ triphosphates, and short or 
absent poly-A tails (Barbalat et al. 2011; Moon and Wilusz 2013). From mammals to arthropods, 
RNA-binding proteins can recognize these foreign RNA motifs and trigger a range of antiviral 
responses. Diverse helicases recognize viral RNAs; mammalian RIG-I and MDA5 recognize 5’ 
triphosphates and long dsRNAs, respectively, to induce antiviral transcriptional responses 
(Hornung et al. 2006; Kato et al. 2006; Pichlmair et al. 2006), and DDX17 recognizes bunyaviral 
RNA stem-loops to restrict infection in both Drosophila and human cells (Moy et al. 2014a). Other 
RNA-binding proteins have been implicated in recognition or restriction of viral RNAs suggesting 
that there are additional players to be discovered (Guo et al. 2004; Miyashita et al. 2011; Dong et 
al. 2016). 
Emerging evidence suggests that viral RNAs are targeted for decay. RNASEL, which is induced 
by interferon signaling, non-specifically degrades both viral and cellular RNA as a step toward cell 
death (Hassel et al. 1993; Castelli et al. 1997; Brennan-Laun et al. 2014). In contrast, recent 
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studies have shown that 5’ exonucleases and decapping machinery selectively target flaviviruses 
and bunyaviruses respectively (Hopkins et al. 2013; Moon and Wilusz 2013; Hopkins et al. 2015). 
The 3’ to 5’ RNA exosome and its associated co-factor complexes have been implicated in some 
immune functions, but are less understood. Early work showed that the yeast Ski complex 
restricts dsRNA viruses, though the mechanism is not clearly understood (Masison et al. 1995; 
Anderson and Parker 1998; Benard et al. 1998). More recently, the human Ski component 
hSKIV2L has been shown to regulate endogenous RIG-I RNA targets to prevent autoimmunity; 
however, it likely does so independent of the canonical Ski complex and the exosome (Eckard et 
al. 2014). Additionally, other mammalian antiviral RNA-binding proteins (ZAP, DDX60, and AID) 
have been shown to bind the exosome and in some cases depend on the exosome for their 
antiviral function; however, none of these factors has been shown to induce exosome-mediated 
degradation of viral RNAs (Guo et al. 2007; Miyashita et al. 2011; Liang et al. 2015). Furthermore, 
no studies have explored potential roles of the nuclear exosome cofactors in viral infection.  
We performed a series of RNAi screens to identify previously unknown RNA processing factors 
that restrict RNA viruses. First, we screened a library of 177 genes implicated in RNA biology in 
Drosophila cells (Zhou et al. 2008) against two disparate arthropod-borne RNA viruses 
(arboviruses): vesicular stomatitis virus (VSV) and Sindbis virus (SINV). VSV is a negative-sense 
rhabdovirus which causes oral and skin lesions in livestock and an influenza-like fever in humans 
(Letchworth et al. 1999). SINV, a positive-sense alphavirus, causes chronic polyarthritic disease 
(Kurkela et al. 2005). Second, we mined our previously-published genome-wide RNAi screen 
against Rift Valley Fever virus (RVFV), a tri-segmented negative-sense bunyavirus which causes 
a febrile illness with 1-3% mortality in humans as well as abortions and juvenile mortality in 
livestock (Bird et al. 2009; Hopkins et al. 2013). The screens converged on the identification of 
the two exosome-associated exonucleases, Rrp6 and Dis3, as antiviral against all three viruses in 
insect cells. Since the exonucleases may have functions outside of the RNA exosome (Schneider 
et al. 2007; Callahan and Butler 2008; Kiss and Andrulis 2011), we tested the role of two core 
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exosome structural components, Rrp4 and Rrp41, and found that these also restrict infection. 
Since the exosome does not target RNAs directly but uses cofactor complexes, we screened 
orthologs of three major cofactor complexes, Ski, NEXT, and TRAMP, for their roles in viral 
infection. These studies revealed that only the TRAMP-associated helicase dMtr4 (l(2)35Df) and 
TRAMP-associated zinc-finger RNA-binding protein dZcchc7 (CG9715) are antiviral in flies. We 
extended our studies to human cells where we found that the broadly antiviral role for the RNA 
exosome and TRAMP orthologs hMTR4 and hZCCHC7 is conserved. Mechanistically, we found 
that infection with these cytoplasmic viruses induces the export of hMTR4 and hZCCHC7, which 
are nuclear in uninfected cells, to the cytoplasm, where they form a complex with the exosome as 
well as viral RNAs. Furthermore, we found that viral RNAs are shortened at the 3’ end and are 
stabilized by disruption of the exosome or the RNA binding protein hZCCHC7. Additionally, we 
found that the RVFV mRNA 3’ UTR confers exosomal regulation. These findings show that a 
virus-induced cytoplasmic TRAMP-like complex specifically targets viral RNAs for exosome-
mediated degradation to attenuate infection. 
Results 
RNAi screen identifies the RNA exosome as antiviral in Drosophila cells 
We previously identified an antiviral role in Drosophila for dArs2 and the nuclear cap-binding 
complex through RNA silencing (Sabin et al. 2009). We hypothesized that additional genes 
involved in RNA metabolism and degradation have antiviral roles against RNA viruses, so we 
conducted a targeted RNAi screen against a panel of 177 genes with previously characterized 
roles in RNA metabolism in Drosophila cells, including dArs2 (Zhou et al. 2008). In order to 
identify broadly antiviral genes, this gene set was screened against two disparate arthropod-
borne viruses: VSV and SINV. Drosophila DL1 cells were treated with previously validated 
double-stranded RNAs (dsRNAs) targeting each gene in the panel and knockdown was allowed 
to proceed for three days, after which cells were infected with GFP-expressing VSV or SINV and 
percent infection was quantified by automated fluorescence microscopy. Each screen was 
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performed in duplicate, and genes with robust Z-scores ≥ 2 for percent infection in both replicates 
(p<0.001) were considered antiviral hits. Using these metrics, the positive control dArs2 as well 
as 25 other genes were antiviral against both viruses (Table 1). One of these hits, dRrp6, is a 
catalytic 3’-5’ exonuclease associated with the RNA exosome, and the only member of the RNA 
exosome in the 177-gene screening set (Figure 3A,B). We compared these data to our published 
genome-wide RVFV screen and found that another exosome-associated exonuclease, dDis3, 
was a validated antiviral hit (Hopkins et al. 2013). The identification of exosome components in 
multiple screens suggested a broadly antiviral role, and thus we focused on the exosome for 
further study. 
Since these exonucleases can potentially function outside of the canonical exosome (Schneider 
et al. 2007; Callahan and Butler 2008; Kiss and Andrulis 2011), we tested two core components 
of the exosome, dRrp4 and dRrp41. In addition, we validated our screening results using 
independent dsRNAs against dRrp6 and dDis3. Knockdown of dRrp4 and dRrp6 was verified by 
immunoblot of ectopically expressed tagged proteins (Hessle et al. 2009), as antibodies against 
the endogenous proteins are not commercially available (Figure 4A). Depletion of each of these 
genes had little impact on cell viability as measured by cell number (Figure 4B) but led to 
significantly increased infection of VSV, SINV, and RVFV as measured both by 
immunofluorescence microscopy (Figure 3C,D) and RT-qPCR (Figure 3E). The effect of the 
exonucleases dRrp6 and dDis3 on viral RNA was stronger than that of the structural genes dRrp4 
and dRrp41, suggesting the possibility that the exonucleolytic activity of the exosome is limiting. 
Taken together, these studies suggest that the RNA exosome complex restricts a broad range of 
RNA viruses in Drosophila cells. 
Orthologs of TRAMP complex components are antiviral in Drosophila  
The exosome is dependent on RNA-binding cofactor complexes to bring RNA targets to the 
exosome for degradation. The best-characterized of these are the Ski, TRAMP, and NEXT 
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complexes (Lubas et al. 2011; Schneider and Tollervey 2013). The Ski complex is cytoplasmic 
and consists of a DExH/D-box helicase, Ski2, a tetratricopeptide repeat-containing protein, Ski3, 
and a WD repeat-containing protein, Ski8, all of which have characterized Drosophila orthologs 
(Brown et al. 2000; Orban and Izaurralde 2005). Depletion of the three Ski components (dSki2/tst, 
dSki3/CG8777, and dSki8/CG3909) had no significant effect on viral infection (Figure 5B,6A) 
The TRAMP complex, which is nuclear in yeast and nucleolar in humans, consists of a DExH/D-
box helicase, Mtr4, a poly-A polymerase, Trf4/5 (Trf4-1 is the active TRAMP polymerase in 
Drosophila), and a zinc-finger RNA-binding protein, Air1/2 (LaCava et al. 2005; Houseley and 
Tollervey 2008; Nakamura et al. 2008; Fasken et al. 2011; Lubas et al. 2011). The Drosophila 
ortholog of Air1/2 is not well characterized: previous BLAST searches with S. cerevisiae Air1p 
and the human Air ortholog hZCCHC7 found that CG9715 is the closest Drosophila ortholog, 
which we will refer to as dZcchc7 (Fasken et al. 2011; Lubas et al. 2011). Mining of our recent 
RVFV genome-wide RNAi screen revealed that dZcchc7 was also a validated antiviral gene 
(Hopkins et al. 2013).  
In humans, Mtr4 forms an additional nuclear complex called the NEXT (Nuclear Exosome 
Targeting) complex which is excluded from nucleoli (Lubas et al. 2011). This complex is 
composed of hMTR4, hZCCHC8 (a zinc-finger RNA-binding protein similar to hZCCHC7), and 
hRBM7, an RNA-binding motif-containing protein (Guo et al. 2003; Gustafson et al. 2005). 
We tested each of the Drosophila TRAMP orthologs (dMtr4/l(2)35Df, dTrf4-1, and 
dZcchc7/CG9715) as well as the NEXT orthologs (dZcchc8/CG4622 and dRbm7/CG11454) for 
their roles in antiviral defense. While depletion of the TRAMP component dTrf4-1 or the NEXT 
components dZcchc8 and dRbm7 did not increase infection, depletion of dMtr4 or dZcchc7 
significantly increased infection of VSV, SINV, and RVFV both by microscopy (Figure 5A,B) and 
RT-qPCR (Figure 5C). Knockdown of dMtr4 was confirmed by immunoblot of tagged 
overexpressed dMtr4 (Figure 6B), and RT-qPCR of endogenous transcripts for the other genes 
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(Figure 6C). Altogether, this demonstrates that the helicase (dMtr4) and RNA-binding zinc-finger 
(dZcchc7) TRAMP orthologs have a role in control of viral infection in Drosophila cells.  
The exosome and TRAMP orthologs restrict RVFV infection of adult flies 
By taking advantage of genome-wide in vivo RNAi transgenic libraries, we tested the roles of 
exosome and TRAMP genes during infection of adult animals. Because these genes are 
essential, in vivo RNAi was performed in a non-essential organ, the fat body, which is the primary 
target of RVFV infection in adult flies (Moy et al. 2014b). We expressed inverted repeats targeting 
dRrp4, dRrp6, dMtr4, or dZcchc7 in the female fat body (Vidal et al. 2001) and challenged these 
flies with RVFV for 6 days, after which infection was assessed by northern blot. We found that 
depletion of all four genes resulted in a significant increase in RVFV replication compared to 
control (Figure 5D,E). Flies with exosome components depleted in the fat body had similar 
survival to control flies, suggesting that increased viral replication is not due to generalized frailty 
(Figure 6D). These data suggest that the RNA exosome and TRAMP orthologs dMtr4 and 
dZcchc7 are antiviral both in cell culture and at the organismal level. 
The antiviral role of the exosome, Mtr4, and Zcchc7 is conserved from flies to humans 
The RNA exosome and TRAMP have conserved roles from yeast to flies to humans (Houseley 
and Tollervey 2009; Schneider and Tollervey 2013). While some studies have explored the 
human RNA exosome, the human TRAMP components were only recently identified and few 
RNA targets have been characterized (Fasken et al. 2011; Lubas et al. 2011). We tested whether 
the exosome and TRAMP genes hMTR4 and hZCCHC7 also restrict viral infection in human 
cells. We depleted the human exosome exonucleases hRRP6 and hDIS3, the core exosome 
subunits hRRP4 and hRRP41, and the TRAMP components hMTR4 and hZCCHC7 using 
siRNAs in human osteosarcoma cells (U2OS), which are permissive to infection by a large 
number of viruses including VSV, SINV, and RVFV (Moy et al. 2014a). Knockdown was 
confirmed by immunoblot for genes with a commercial antibody we could validate, or RT-qPCR 
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for the remaining genes (Figure 7A,B). Quantification of cell number revealed only modest effects 
on cell number under these conditions (Figure 7C). Cells depleted of exosome, hMTR4, or 
hZCCHC7 and infected with VSV, SINV, or RVFV showed increased viral RNA levels as 
measured by RT-qPCR (Figure 8A) and increased viral protein by immunoblot (Figure 8B-D). 
Together, these data suggest that the RNA exosome and TRAMP components are antiviral in 
human cells against diverse RNA viruses.  
MTR4 and ZCCHC7 form a cytoplasmic complex with the exosome upon viral infection 
While the RNA exosome is present in the nucleus and cytoplasm, the human TRAMP complex is 
thought to be exclusively nucleolar (Fasken et al. 2011; Lubas et al. 2011). However, VSV, SINV, 
and RVFV are all cytoplasmic RNA viruses that are not thought to transport their RNAs into the 
nucleus (Strauss and Strauss 1994; Letchworth et al. 1999; Moon and Wilusz 2013). Therefore, 
we hypothesized that if the TRAMP components were directly targeting viral RNA, they would 
have to relocalize to the cytoplasm during infection. We validated an antibody against hZCCHC7 
both by immunoblot and immunofluorescence (Figure 7B,10A). While we validated an hMTR4 
antibody by immunoblot (Figure 7B), it did not recognize hMTR4 by immunofluorescence (not 
shown). Next, U2OS cells were either mock infected or infected with RVFV or SINV, and 
hZCCHC7 localization was monitored. While hZCCHC7 was exclusively nucleolar in uninfected 
cells, in RVFV- or SINV-infected cells hZCCHC7 accumulated in cytoplasmic punctae (Figure 9A-
D; monochrome images in Figure 10B,C). Furthermore, the average number of cytoplasmic 
punctae per infected cell was similar between RVFV and SINV infection (Figure 10D).  
Next we set out to explore the localization of these factors using biochemical fractionation. 
Nuclear and cytoplasmic lysates were isolated and the purity of fractionation was established by 
monitoring the nuclear protein lamin and the cytoplasmic protein tubulin. As expected, hMTR4 
and hZCCHC7 were detected in the nuclear but not cytoplasmic fraction of uninfected cells 
(Figure 9E). However, upon infection with VSV or SINV, both hMTR4 and hZCCHC7 
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accumulated in the cytoplasm. We also examined localization of the NEXT component hZCCHC8 
since it is similar in structure to hZCCHC7 and also associates with hMTR4 in the nucleus (Lubas 
et al. 2011). In contrast to hMTR4 and hZCCHC7, hZCCHC8 was exclusively nuclear in both 
uninfected and infected cells (Figure 9F, 10E), suggesting that there is specificity in the proteins 
relocalized to the cytoplasm. 
To determine whether the accumulation of these TRAMP components in the cytoplasm was due 
to their export from the nucleus or from increased synthesis, we first examined whether viral 
infection altered overall levels of these proteins and observed no increase upon infection with 
VSV, SINV, or RVFV (Figure 9G). Next, we assessed whether cytoplasmic accumulation was 
dependent on nuclear export by testing whether the major nuclear export protein CRM1, which 
we have previously found to be broadly antiviral (Yasunaga et al. 2014), was required for virus-
induced cytoplasmic accumulation. We validated that siRNA treatment efficiently depleted CRM1 
(Figure 10F). Next, CRM1-depleted or control cells were infected with RVFV, and the nuclear and 
cytoplasmic fractions were isolated. As with VSV and SINV, RVFV infection led to the 
accumulation of hMTR4 and hZCCHC7 in the cytoplasm (Figure 9H). Furthermore, this virus-
induced increase was lost upon CRM1 depletion. These data suggest that signals from viral 
infection induce the export of these antiviral proteins from the nucleus to the cytoplasm. 
The TRAMP components hMTR4 and hZCCHC7 function in the nucleolus as a complex with the 
exosome (Lubas et al. 2011).  We reasoned that in order to target viral RNAs for exosomal 
degradation, these proteins must both relocalize and form a complex in the cytoplasm. To test 
this hypothesis we first expressed FLAG-tagged hMTR4 (Lubas et al. 2011) or a vector control 
and confirmed expression by immunoblot (Figure 12A). Next, transfected cells were infected with 
RVFV or mock infected and anti-FLAG immunoprecipitations were performed.  As expected, 
hMTR4-FLAG immunoprecipitated hZCCHC7 and the exosomal protein hRRP6 in both infected 
and uninfected cells in whole cell lysates (Figure 11A). In contrast, cytoplasmic hMTR4-FLAG 
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precipitated hZCCHC7 and hRRP6 only in RVFV-infected cells (Figure 11B). While the specificity 
of hZCCHC7 co-immunoprecipitation during infection can be explained by its export to the 
cytoplasm, hRRP6 was co-immunoprecipitated only during infection despite having a cytoplasmic 
localization in uninfected cells as well. Co-immunoprecipation of these factors was unchanged 
upon RNase A treatment (data not shown), suggesting that these interactions are not RNA-
dependent.  Taken together, our data indicate that hZCCHC7 and hMTR4 are exported and form 
a complex with the exosome in the cytoplasm upon viral infection. 
ZCCHC7 specifically binds RVFV mRNA and SINV RNA 
In yeast, the zinc-finger-containing Air proteins are thought to confer RNA binding specificity to 
TRAMP, which in turn delivers its RNA cargo to the exosome for degradation (Schmidt et al. 
2012). This led us to hypothesize that hZCCHC7, as the human Air ortholog, may be the 
specificity factor that binds viral RNAs to target them to the exosome. To examine this possibility, 
we performed RNA immunoprecipitation (RNA-IP) with hZCCHC7. We transfected FLAG-tagged 
hZCCHC7 (Lubas et al. 2011) or control vector and verified expression and cytoplasmic 
localization of hZCCHC7-FLAG during infection by immunoblot (Figure 12A). Next, transfected 
cells were infected with RVFV or SINV, and cytoplasmic fractions were collected (input) and a 
fraction was subjected to FLAG-immunoprecipitation followed by RT-qPCR. RNA quantification 
was normalized to vector control for both input and FLAG immunoprecipitation to demonstrate 
that ectopic expression of hZCCHC7 did not increase the input levels and to remove any signal 
from nonspecific RNA binding to beads or FLAG antibody. We found that RVFV nucleocapsid (N) 
and nonstructural (NSs) mRNAs, but not the S segment genome or antigenome from which they 
were transcribed, were selectively and significantly bound by hZCCHC7 (Figure 13A; schematic 
of RNAs in Figure 12B). This selective binding is not explained by RNA abundance, as northern 
blot analysis revealed that N mRNA levels are lower than those of S segment 
genome/antigenome in both Drosophila and humans ((Figure 5D) and (Moy et al. 2014b)). An 
endogenous mRNA, hDCP2 (the levels of which are unaffected by RVFV infection (Hopkins et al. 
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2015)), was not significantly bound. Similar results were found for SINV infection, in which SINV 
genomic and subgenomic RNAs, which function as mRNAs, were significantly bound by 
hZCCHC7 (Figure 13B). These data suggest that hZCCHC7 selectively binds viral mRNAs in the 
cytoplasm during infection.  
RVFV mRNA, but not genomic or antigenomic RNA, is shortened at the 3’ end 
The exosome processively degrades RNA 3’ to 5’; however, RNAs partially degraded by the 
exosome can leave 3’ truncated degradation intermediates (Eckwahl et al. 2015). Since we found 
that hZCCHC7 selectively bound RVFV mRNA, but not RVFV genomic or antigenomic RNA, we 
hypothesized that the mRNA would be truncated at the 3’ end. To test this, 3’ rapid amplification 
of cDNA ends (3’ RACE) was performed and individual RNAs were sequenced. Briefly, RNA was 
harvested from RVFV-infected cells and a linker was ligated to the 3’ end of the RNA. RT-PCR 
was then performed using a linker-specific reverse primer and a virus-specific forward primer 
targeting S segment genomic RNA, antigenomic RNA, or nucleocapsid (N) mRNA. PCR products 
were cloned and individual clones were sequenced to identify the proportion of full length clones. 
We classified reads as full length or shortened based on the full length sequences of the genomic 
segment as well as the transcription termination site that defines the 3’ end of the N mRNA, N 
coding sequence (ORF), and 3’UTR (Ikegami et al. 2007). 3’ RACE revealed that while most 
sequence reads from genomic and antigenomic S segment RNA clones were full-length, the 
majority of N mRNA reads were shortened at the 3’ end (Figure 14A). A variety of truncated N 
mRNA sequences were found with both intact and disrupted N coding sequence (Figure 14B). 
This suggests that the viral mRNA, but not genomic or antigenomic RNA, is subject to 3’ 
degradation. 
RVFV mRNA stability is dependent on the exosome and ZCCHC7 
Bunyaviruses such as RVFV are unique in that mRNA transcription but not the replication of the 
genome requires concomitant protein translation (Barr 2007). Cycloheximide, which inhibits 
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translational elongation, can therefore be used to block new mRNA synthesis, allowing us to 
assess the rate of decay of previously transcribed RVFV mRNA (Hopkins et al. 2013). To 
determine whether the stability of RVFV mRNA is exosome- and hZCCHC7-dependent, we 
depleted the two exosome exonucleases, hRRP6 and hDIS3, or hZCCHC7, by siRNA in U2OS 
cells.  Cells were infected with RVFV (MOI = 1, 12h) and treated with cycloheximide for 0, 1, or 2 
hours and RNA was processed for RT-qPCR. As previously observed (Hopkins et al. 2013), we 
found that RVFV mRNA significantly decayed after addition of cycloheximide in control cells 
(Figure 14C), but RVFV genome/antigenome did not (Figure 12C). Furthermore, we observed 
that depletion of hRRP6/hDIS3 or hZCCHC7 significantly reduced this decay, suggesting that 
RVFV mRNA is destabilized by the RNA exosome and hZCCHC7. 
The RVFV NSs 3’ UTR is specifically regulated by the exosome during infection 
We set out to determine if there are specific signals in the RVFV mRNA that direct exosomal 
degradation. Since cellular mRNAs are often targeted to the exosome through signals at the 3’ 
end including hypoadenylation, 3’ extension, and AU-rich elements in the 3’ UTR (Chen et al. 
2001; Milligan et al. 2005; Lubas et al. 2015), we hypothesized that the 3’ UTR of a RVFV mRNA 
would be sufficient to render an mRNA susceptible to control by the exosome. To test this, we 
used a reporter system in which the RVFV NSs 3’ UTR is cloned downstream of a cGFP ORF. 
Since the mRNAs of RVFV are not polyadenylated, we generated the exact 3’ end by cloning the 
mascRNA sequence downstream of the 3’UTR, which is processed by endogenous RNase P, 
leaving the mature viral 3’ end (Figure 15A-D) (Wilusz et al. 2012). U2OS cells stably expressing 
this reporter or a control reporter with the SV40 polyadenylation signal cloned downstream of 
cGFP were transfected with siRNAs targeting hRRP6 and hDIS3 or control and either mock 
infected or infected with RVFV (MOI = 10, 18h). Automated fluorescence microscopy was used to 
calculate the percent of cells expressing cGFP. We found that while the NSs 3’ UTR reporter was 
unaffected by exosome depletion in uninfected cells, RVFV infection caused a significant 
reduction in reporter signal that was rescued to uninfected control levels by exosome depletion 
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(Figure 14D). In contrast, the SV40 poly A reporter was unaffected by either exosome depletion 
or viral infection. This demonstrates that upon viral infection the exosome specifically regulates 
the RVFV 3’ UTR, but not a conventional polyadenylated mRNA. 
Discussion 
Increasing evidence suggests that the RNA recognition and decay machinery plays an important 
role in the control of viral infection. Through RNAi screening, we found that the RNA exosome 
and two components of the exosomal cofactor TRAMP complex were antiviral against diverse 
RNA viruses from insects to humans.  
Since the TRAMP complex normally binds specific RNAs for exosome-dependent processing, we 
hypothesized that the antiviral TRAMP components would recognize viral RNAs and recruit the 
exosome to degrade them. However, human TRAMP is thought to exclusively reside in the 
nucleolus (Fasken et al. 2011; Lubas et al. 2011); therefore, we tested whether these antiviral 
TRAMP components translocate upon infection to the cytoplasm, where the viral RNAs are 
located. Indeed, we found that hMTR4 and hZCCHC7 are dependent on the nuclear export 
protein CRM1 for their cytoplasmic accumulation and associate with each other and the exosome 
in the cytoplasm during infection. In contrast, the related NEXT complex component hZCCHC8 
remained exclusively nuclear during infection, suggesting that the export of antiviral TRAMP 
components to the cytoplasm is specific. Furthermore, immunofluorescence analysis revealed 
infection-induced hZCCHC7 cytoplasmic punctae. The RNA exosome and some cofactors have 
previously been found in cytoplasmic granules distinct from P bodies or stress granules (Sheth 
and Parker 2003; Graham et al. 2006; Lin et al. 2007). These data suggest that hZCCHC7 and 
hMTR4 accumulate in exosome granules during viral infection to facilitate the specific 
degradation of viral RNA. 
The virus-induced translocation of antiviral factors from the nucleus to the cytoplasm is an 
emerging theme; we previously found that two additional RNA-binding proteins, DDX17 and 
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Drosha, are exported during infection for their roles in antiviral defense (Moy et al. 2014a; Shapiro 
et al. 2014). Furthermore, we have found CRM1 to be broadly antiviral in both Drosophila and 
human cells (Yasunaga et al. 2014), suggesting that this is at least in part related to the 
requirement for the export of antiviral RNA-binding proteins. The sensors necessary for export of 
these effectors of antiviral defense are not yet well understood; we hypothesize that detection of 
virus-specific signals such as dsRNA by sensors like RIG-I, MDA5, or PKR may trigger export of 
hMTR4 and hZCCHC7. Indeed, PKR sensing of viral RNA has been shown to induce the 
formation of antiviral stress granules in the cytoplasm, opening the possibility that a similar 
process may induce hZCCHC7 granules (Onomoto et al. 2012). 
Next, we investigated whether this exported complex binds viral RNA. We found that RVFV and 
SINV mRNA are bound by hZCCHC7, but RVFV genome, RVFV antigenome, and an 
endogenous mRNA are not. This specificity may be explained at least in part by accessibility; 
bunyaviral genome and antigenome RNAs are coated by nucleocapsid and as such may not be 
accessible to cellular degradation machinery, while mRNA must be accessible in order to be 
translated and thus is vulnerable to RNases (Kolakofsky and Hacker 1991; Strauss and Strauss 
1994). Furthermore, 3’ RACE revealed that while RVFV S segment genome and antigenome 
were largely full-length, the majority of RVFV N mRNA was shortened at the 3’ end. Though 
RVFV N mRNA has been studied using 3’ RACE, previous studies only sequenced pooled and 
size-selected RACE products, which would mask shortened ends (Albarino et al. 2007; Lara et al. 
2011). This led us to test whether the exosome impacts the stability of viral mRNAs. Using 
cycloheximide to disrupt protein translation and thus RVFV mRNA transcription (Barr 2007), we 
found that RVFV mRNA decay is exosome- and hZCCHC7-dependent and that the genomic RNA 
is not subject to this targeting.  
This specificity suggests that there may be signals or sequences in the viral mRNAs that direct 
their decay. Indeed, the exosome degrades several classes of mRNAs based on signals in their 
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3’ UTR’s. Therefore, we tested whether the 3’ UTR of RVFV mRNA confers this specificity and 
found that the RVFV NSs 3’ UTR directs exosome-dependent decay only during RVFV infection. 
This regulated decay of viral mRNAs is reminiscent of other cohorts of mRNAs, known as RNA 
regulons, which are co-regulated through signals in their 3’ UTRs such as AU-rich elements or C-
rich motifs; regulation of these RNAs is also exosome-dependent (Chen et al. 2001; Mukherjee et 
al. 2002; Keene 2007; Singer et al. 2012; Blackinton and Keene 2014). 
We characterized a new role for an RNA-binding exosome cofactor complex that is regulated by 
infection to specifically target viral RNAs for exosome-dependent degradation. This may be part 
of a larger spectrum of exosomal co-factors activated during infection. The antiviral RNA-binding 
proteins DDX17, DDX60, ZAP, and AID have all been found to co-immunoprecipitate with the 
exosome (Guo et al. 2007; Lubas et al. 2011; Miyashita et al. 2011; Moy et al. 2014a; Liang et al. 
2015). Furthermore, both ZAP and AID restrict viral infection only if the exosome is intact. Further 
studies are needed to determine if these complexes drive exosomal degradation of viral RNAs. 
Nevertheless, taken together with the current study, these data suggest that viral infection may 
induce a panel of RNA binding cofactor complexes to target viral RNAs for selective exosome-
dependent decay.  
Materials and Methods 
Cells, viruses, antibodies, and reagents 
Drosophila DL1 cells and human U2OS cells were grown and maintained as previously described 
(Cherry and Perrimon 2004; Moser et al. 2012). VSV-eGFP (gift from J. Rose) was grown in BHK 
cells as described (Ramsburg et al. 2005). SINV-GFP (gift from R. Hardy) and SINV-mKate (gift 
from M. Heise) was grown in C636 cells as described (Burnham et al. 2007).  An attenuated 
strain of RVFV (MP-12) was grown in Vero cells as described (Filone et al. 2010). Viral titers were 
calculated by plaque assay on BHK cells. Primary antibodies to GFP, CRM1, and Beta-actin were 
obtained from Santa Cruz. Antibodies to hRRP6 (EXOSC10), hMTR4 (SKIV2L2), hZCCHC8, and 
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lamin B1 were obtained from Abcam. Antibodies to hZCCHC7 and alpha-tubulin were obtained 
from Sigma. Primary antibodies to RVFV N and Gn were gifts from R. Doms. Fluorescent 
secondary antibodies were obtained from Invitrogen, and HRP-conjugated antibodies were from 
Amersham. Other chemicals were purchased from Sigma. 
Drosophila RNAi 
Double-stranded RNAs (dsRNAs) were generated as described (Boutros et al. 2004). 
Knockdowns for RNAi screening were performed in 384 well plates pre-arrayed with 0.25µg of 
dsRNA per well, as described (Zhou et al. 2008; Hopkins et al. 2013). Briefly, to knock down 
genes using RNAi, DL1 cells were passaged into serum-free media and seeded into plates 
containing dsRNAs targeting the indicated genes or β-galactosidase as a non-targeting control. 
Cells were serum starved for one hour, after which complete media was added and cells were 
incubated for 3 days. Knockdown was validated by co-transfection of dsRNAs with plasmids 
expressing dRrp4-V5, dRrp6-V5, or dMtr4-FLAG using Effectene transfection reagent (Qiagen) 
(Hessle et al. 2009). 
Mammalian RNAi 
Ambion Silencer Select siRNAs were used for all genes except hCRM1, for which a Santa Cruz 
siRNA was used. Transfection into U2OS cells was performed using HiPerFect (Qiagen) as per 
the manufacturer’s protocol. Cells were incubated for 3 days. Silencer Select Negative Control #2 
(Ambion) was used as a non-targeting control. 
Viral infections 
Three days post-RNAi, cells were infected with the indicated viruses. MOI was calculated based 
on viral titers on BHK cells. For DL1 cells, VSV-GFP (MOI = 0.1) was processed at 24 hpi. SINV-
GFP (MOI = 2.5) and RVFV (MOI = 0.1) were spinoculated at 1200 rpm for 2 h and processed at 
36 and 30 hpi, respectively. For infectivity studies in U2OS cells, VSV-GFP (MOI = 0.05), SINV-
GFP (MOI = 1) and RVFV (MOI = 0.03) were added to cells in complete media for 14, 16, and 18 
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hours respectively for RNA, or 14, 8, and 18 hours respectively for protein. For 
immunofluorescence localization studies, U2OS cells were infected with RVFV or SINV-mKate 
(MOI = 10) for 12 and 5 hours respectively. For fractionation and immunoprecipitation, U2OS 
cells were infected with VSV-GFP (MOI = 10, 8h), SINV-GFP (MOI = 10, 8h), or RVFV (MOI = 10, 
12h). 
Immunofluorescence 
Cells were processed as previously described (Shelly et al. 2009). Cells were imaged with an 
ImageXpress Micro automated microscope. At least four sites in each of three wells were imaged 
per condition per experiment, and MetaXpress cell scoring was used to calculate the number of 
cells and percent infection. For protein relocalization studies, U2OS cells grown on coverslips 
were imaged with a Leica DMI 4000 B fluorescent microscope. MetaXpress software was used to 
quantify cytoplasmic hZCCHC7 punctae between .8 and 2 µm in size in mock infected and 
infected cells (infection was verified by immunofluorescence for each cell to be quantified) with at 
least 25 cells quantified per condition. All experiments were performed at least three times. 
RNA quantification 
Total RNA was extracted and northern blotting or RT-qPCR were performed as previously 
described (Cherry 2005; Xu et al. 2012). Primer sequences are described below. 
Adult fly infections 
Transgenic flies for in vivo RNAi were obtained from the Vienna Drosophila RNAi Center (UAS-
dRrp4 IR, UAS-dMtr4 IR, UAS-dZcchc7 IR) or Bloomington Drosophila Stock Center (UAS-dRrp6 
IR) and crossed to Yp1-GAL4, which was also obtained from Bloomington. 4-7 day old flies were 
challenged with RVFV (Cherry and Perrimon 2004) and 15 flies per condition were processed for 
RNA 6 days post-infection as previously described (Xu et al. 2012).  
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Nuclear/cytoplasmic fractionation 
Cells were lysed in Buffer A (30 mM Hepes pH 7.4, 2 mM MgOAc, .1% NP40) supplemented with 
5 mM DTT, PMSF, and protease inhibitors (Roche complete tablets, 25x) by pipetting three times 
through a 26g needle. Nuclei were pelleted for 20 minutes at 500g. Cytoplasmic supernatant was 
removed and the nuclear pellet was rinsed twice with Buffer A, then lysed with sonication in RIPA 
buffer (50 mM Tris-HCl pH 7.4, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 150 mM NaCl, 2 
mM EDTA, 50 mM NaF) supplemented with PMSF and protease inhibitors. Lysates were 
analyzed by immunoblot. Each experiment was repeated at least three times and representative 
blots shown. 
Immunoprecipitation 
U2OS cells were transfected with doxycycline-inducible hMTR4-FLAG, hZCCHC7-FLAG, or 
empty vector control, using Xtremegene 9 (Roche) (Lubas et al. 2011). Plasmid expression was 
induced at 24 hours with 1 µg/mL doxycycline and cells were infected at 48 hours with RVFV 
(MOI = 10) for 12h. Cytoplasmic extracts or whole cell lysates were immunoprecipitated with anti-
FLAG M2 magnetic beads (Sigma). For analysis of proteins, beads were treated with 100ug/mL 
RNase A or untreated, washed with Buffer A and analyzed by immunoblot. For analysis of bound 
RNA, beads were washed in Buffer A supplemented with 150 mM NaCl and .5% NP40 and 
analyzed by RT-qPCR for efficient expression of the construct and target RNA binding. Each 
experiment was repeated at least three times and representative blots shown. 
3’ RACE 
3’ RACE was performed as previously described (Wilusz et al. 2008). U2OS cells were infected 
with RVFV (MOI = 0.3) for 18 hours. Total RNA was harvested and treated with CIP (New 
England Biolabs) to remove terminal phosphates, ligated to miRNA linker #3 (IDT) and reverse 
transcribed using a linker-specific primer. RACE PCR was performed against S segment 
genome, antigenome, or N mRNA (see Supplement for primers) and products were cloned using 
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TOPO-TA (Invitrogen). Individual colonies were screened for insert with colony hybridization 
Southern blot and sequenced. Sequences were classified based on previous studies of RVFV 
transcriptional termination (Ikegami et al. 2007). 
RNA stability assay 
Three days post-RNAi, cells were infected with RVFV (MOI = 1) for 12 hours. Cells were treated 
with 50 µg/ml cycloheximide for 0, 1, or 2 hours, after which cells were processed for RT-qPCR.  
DCP2 was used as a control. 
GFP 3’ UTR reporters 
To generate plasmids encoding cGFP-3’ UTR reporters, the previously described pCRII-TOPO 
CMV-cGFP-SV40 Poly(A) Sense plasmid (Wilusz et al. 2012) was cleaved by the NotI restriction 
enzyme to remove the SV40 polyadenylation signal. The 3’ UTR of RVFV NSs, RNase P 
cleavage site, and mascRNA sequences, flanked by NotI sites (sequence: 
GCGGCCGCAGGTTAAGGCTGCCCCACCCCCCACCCCCTAATCCCGACCGTAACCCCAACT
CCCCTTCCCCCCAACCCCCTGG 
GACGCTGGTGGCTGGCACTCCTGGTTTCCAGGACGGGGTTCAAGTCCCTGCGGTGTCTTTG
CTTGCGGCCGC) were then inserted downstream of the cGFP ORF. The original plasmid 
expressing cGFP with a downstream SV40 polyadenylation signal was used as a control. Proper 
processing of cGFP mRNA and mascRNA was validated by northern blot and small RNA 
northern blot, respectively. Expression of cGFP protein was validated by western blot. Stable cell 
lines were generated and used for immunofluorescence experiments. 
Oligonucleotide sequences 
qVSV N F CGGAGGATTGACGACTAATGC 
qVSV N R ACCATCCGAGCCATTCGA 
qSINV Nsp1/genomic F GCTGAAACACCATCGCTCTGCTTT 
qSINV Nsp1/genomic R TGGTGTCGAAGCCAATCCAGTACA 
qRVFV N F CAAGCAGTGGACCGCAATGAGA 
qRVFV N R GGGCTTGTTGCCACGAGTTAGA 
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RVFV N northern F CATCTAATATTGCCCTTAGA 
RVFV N northern R TTACAATAATGGACAACTAT 
dRps6 northern F GCCGTGTGCGTCTGCTCCTG 
dRps6 northern R TTACTTCTTGTCGCTGGAGA 
qdRp49 F AAGAAGCGCACCAAGCACTTCATC 
qdRp49 R TCTGTTGTCGATACCCTTGGGCTT 
qdZcchc7 F TGGATAGCCGGGTACAGTATAG 
qdZcchc7 R TGCTACGAAAGTCACCAATCC 
qdZcchc8 F CTGCCGAGTCCGGAAATAAT 
qdZcchc8 R CACAGGCAGTCTGTCGTAAA 
qdRbm7 F GCCATCACTACGTCCGATTT 
qdRbm7 R CCGACGCACCACTATACATTT 
qdTrf4-1 F CCTGTGGAGCACAAAGATCA 
qdTrf4-1 R GCTTCGTCCTTTCACCTCTATC 
qdTrf4-2 F AGGAGATCGAGCAGTTCTACA 
qdTrf4-2 R CAAATGGAAAGCACCACATCC 
qdSki2 F GGGAGCACCAAGAAGAGAAA 
qdSki2 R CTTTCCTCCAGCACCAGTATAG 
qdSki3 F GTCGTTCCAGGGATTTCTCTAC 
qdSki3 R CTCCAGGTTCGCACAACTTA 
qdSki8 F CAGGAGGACAACACCCTAAAG 
qdSki8 R ATGGTGGAGTCCAGAGAACTA 
qhGAPDH F ACCAAATCCGTTGACTCCGACCTT 
qhGAPDH R TCGACAGTCAGCCGCATCTTCTTT 
3' RACE S genome F GCATCAAACCCTTGATAAGCAAACTCTC 
3' RACE S antigenome F GTGACTAGGACGATGGTGCATGAGAAAG 
3' RACE N F CACGCAGCCAATGAATGCAGC 
3' RACE adapter primer R GACTAGCTGGAATTCGCGGTTAAA 
qRVFV genome antigenome F CTTTATAAGCCATGAGAAGAGGAGAG 
qRVFV genome antigenome R GGAGGAGAGCCTGATGCTGC 
qhRRP4 F CACCTGTAGTCCCAGCTATTTG 
qhRRP4 R GGAGTGTGGTACGCGATTT 
qhRRP41 F GGCCCTAGTGAACTGTCAAT 
qhRRP41 R GCCCATCTCACAGGACTTAC 
qhDIS3 F GCTAAGCAGGTTACGTGGAATA 
qhDIS3 R GCAGTGTGAGAACAGACCATAA 
qhDCP2 F TGCAGAACACACCAGGATTAC 
qhDCP2 R CACATCTTCACCTTGAGGCA 
qSINV subgenomic F AACACCACCACCATGAATAGA 
qSINV subgenomic R GTCAGTTGCTGGATTTGAGAAG 
qhZCCHC7 F CAGACATCGTGAAGTGGATGAG 
qhZCCHC7 R GAACGGTGAAAGGGCTTAGAA 
cGFP northern probe TCCATGCCGTGGGTGATGCC 
beta-actin northern probe AGCACTGTGTTGGCGTACAG 
mascRNA northern probe GCAAAGACACCGCAGGGATTTGAAC 
CCCGTCCTGGAAACCAGGAGTGCCA 
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U6 northern probe GCTAATCTTCTCTGTATCGTTCC 
AATTTTAGTATATGTGCTGCCG 
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Table 1: Antiviral screen hits in VSV and SINV 
 Z % INFECTION RANK ORDER 
Gene VSV 
A 
VSV 
B 
SINV 
A 
SINV 
B 
VSV 
A 
VSV 
B 
SINV 
A 
SINV 
B 
Ago1 3.061 2.951 3.360 3.988 21 19 19 18 
Ars2 3.933 3.326 3.699 4.344 12 15 12 12 
Bx42 3.837 3.285 2.152 2.092 14 16 26 26 
Cbp20 3.354 3.720 3.602 4.335 18 10 15 13 
Cbp80 3.484 2.755 3.119 3.547 15 21 21 23 
CG7185 3.274 2.987 2.945 3.407 19 18 24 24 
Dsor1 2.677 2.558 3.669 4.190 23 25 13 16 
eIF-4a 3.464 3.333 3.783 4.375 16 14 11 10 
hrg 3.126 3.118 2.988 3.703 20 17 23 21 
l(1)10Bb 4.849 3.944 3.617 4.372 4 6 14 11 
l(2)01424 2.629 2.849 3.369 3.906 25 20 18 19 
noi 2.859 2.603 3.438 4.235 22 24 17 15 
Pep 2.648 3.387 4.468 5.954 24 13 2 1 
RpL21 4.566 4.052 3.233 4.121 8 3 20 17 
RpL22 4.671 4.000 3.455 4.283 7 5 16 14 
RpL5 3.971 4.015 3.025 3.646 11 4 22 22 
RpS13 4.790 4.098 4.337 5.093 5 2 3 2 
RpS15 4.749 3.692 4.142 4.643 6 11 6 7 
RpS26 4.292 3.836 4.075 4.567 10 8 9 9 
RpS28b 3.895 2.698 4.226 4.826 13 23 5 4 
RpS30 4.339 3.690 3.868 4.934 9 12 10 3 
RpS6 5.057 4.144 4.142 4.810 1 1 7 5 
RpS7 4.935 3.916 4.128 4.634 2 7 8 8 
RpS9 4.858 3.767 4.281 4.792 3 9 4 6 
Rrp6 3.381 2.314 2.400 3.188 17 26 25 25 
Sos 2.525 2.716 4.479 3.757 26 22 1 20 
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Figure 3: The RNA exosome is broadly antiviral in Drosophila cells. A panel of 177 genes 
with roles in RNA biology were depleted by RNAi in DL1 cells for three days and infected with (A) 
VSV-GFP (MOI 0.1, 24h), or (B) SINV-GFP (MOI 2.5, 36h) and screened by immunofluorescence 
measuring the percentage of infected cells. Robust Z-scores are shown for two replicates. These 
screens identified the positive control dArs2 (red) and the exosome component dRrp6 (green). 
(C) DL1 cells were treated with dsRNAs targeting the indicated genes or negative control dsRNA 
targeting β-galactosidase and infected with VSV-GFP (MOI 0.1, 24h), SINV-GFP (MOI 2.5, 36h), 
or RVFV (MOI 0.1, 30h), and subsequently processed for automated immunofluorescence 
microscopy for GFP or RVFV nucleocapsid. Representative images are shown with quantification 
of percent infected cells. (D) Mean±SEM of at least 3 experiments as shown in B normalized to 
control. Mean percent infection in control cells was 5.40% (VSV), 3.80% (SINV), and 5.62% 
(RVFV). *p<0.05 compared to control by Student’s t-test. (E) Cells were infected as above and 
processed for RT-qPCR for VSV N, SINV Nsp1, or RVFV N compared to the housekeeping gene 
Rp49. Mean±SEM normalized to control shown (n≥3). *p<0.05 compared to control by Student’s 
t-test. A-B in collaboration with Leah Sabin. C-E in collaboration with Ryan Moy. 
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Figure 4: The RNA exosome can be depleted in Drosophila cells. (A) DL1 cells were co-
transfected with the indicated expression vectors and the indicated dsRNAs. 48 hours later cells 
were processed for anti-V5 immunoblot. A representative blot is shown (n=2). (B) DL1 cells were 
treated with the indicated dsRNAs and infected with RVFV (MOI 0.1, 30h), and subsequently 
processed for automated immunofluorescence microscopy and quantification of nuclei. 
Mean±SEM normalized to control is shown (n≥3). B in collaboration with Ryan Moy. 
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Figure 5: TRAMP orthologs dMtr4 and dZcchc7 are antiviral in Drosophila. (A) DL1 cells 
were treated with dsRNAs targeting the indicated genes or negative control dsRNA targeting β-
galactosidase and infected with VSV-GFP (MOI 0.1, 24h), SINV-GFP (MOI 2.5, 36h), or RVFV 
(MOI 0.1, 30h), and subsequently processed for automated immunofluorescence microscopy for 
GFP or RVFV nucleocapsid. Representative images are shown with quantification of percent 
infected cells. (B) Mean±SEM of at least 3 experiments as shown in A normalized to control. 
*p<0.05 compared to control by Student’s t-test. (C) Cells were infected as above and processed 
for RT-qPCR for VSV N, SINV Nsp1, or RVFV N compared to the housekeeping gene Rp49. 
Mean±SEM normalized to control shown (n≥3). *p<0.05 compared to control by Student’s t-test. 
(D) Adult flies depleted of exosome or TRAMP genes in the fat body (YP1-Gal4 > IR) or controls 
(YP1-Gal4 > +) were challenged with RVFV for 6 days then processed for northern blot. A probe 
which identified the S segment genome/antigenome and the N mRNA was used. The 
housekeeping gene RpS6 was used as a loading control. (E) Quantification of RVFV N mRNA 
from ≥3 experiments as shown in D. Mean±SEM normalized to control. *p<0.05 compared to 
control by Student’s t-test. A-C in collaboration with Ryan Moy. D-E in collaboration with Beth 
Gold. 
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Figure 6: Exosome cofactors can be depleted in Drosophila. (A) DL1 cells were treated with 
the indicated dsRNAs and infected with VSV-GFP (MOI 0.1, 24h), SINV-GFP (MOI 2.5, 36h), or 
RVFV (MOI 0.1, 30h), and subsequently processed for RT-qPCR for the indicated viruses 
compared to the housekeeping gene Rp49. Mean±SEM normalized to control is shown (n=3). (B) 
DL1 cells were co-transfected with a FLAG-dMtr4 expression vector and the indicated dsRNAs. 
48 hours later cells were processed for anti-FLAG immunoblot. A representative blot is shown 
(n=2). (C) DL1 cells were treated with the indicated dsRNAs and subsequently processed for RT-
qPCR for the depleted genes relative to control. Mean normalized to control is shown (n=2). (D) 
Adult flies depleted of exosome or TRAMP genes in the fat body (YP1-Gal4 > IR) or controls 
(YP1-Gal4 > +) were challenged with RVFV for 6 days and survival was quantified. Mean±SEM is 
shown (n≥3). D in collaboration with Beth Gold. 
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Figure 7: RNA exosome and TRAMP orthologs can be depleted in human cells. (A) U2OS 
cells were transfected with the indicated siRNAs for 72h, then processed for RT-qPCR for the 
indicated genes compared to the housekeeping gene GAPDH. Mean±SEM normalized to control 
is shown (n≥3). *p<0.05 compared to control by Student’s t-test. (B) U2OS cells were transfected 
with the indicated siRNA’s for 72h, and subsequently processed for immunoblot. A representative 
blot is shown (n≥3). (C) U2OS cells were transfected with the indicated siRNAs and infected with 
RVFV (MOI .03, 18h), and subsequently processed for automated immunofluorescence 
microscopy. Mean±SEM of the number of nuclei in at least 3 experiments is shown normalized to 
control. 
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Figure 8: The RNA exosome and TRAMP orthologs are antiviral in human cells. (A) U2OS 
cells were transfected with the indicated siRNAs and infected with VSV-GFP (MOI 0.05, 14h), 
SINV-GFP (MOI 1, 16h), or RVFV (MOI 0.03, 18h), and subsequently processed for RT-qPCR for 
VSV N, SINV Nsp1, or RVFV N compared to the housekeeping gene GAPDH. Mean±SEM shown 
normalized to control (n≥3). *p<0.05 compared to control by Student’s t-test. (B) Cells were 
transfected with the indicated siRNAs and infected with VSV-GFP (MOI 0.05, 14h), then 
processed for GFP immunoblot. A representative blot is shown (n≥3). (C) Cells were transfected 
with the indicated siRNAs and infected with SINV-GFP (MOI 1, 8h), then processed for GFP 
immunoblot. A representative blot is shown (n≥3). (D) Cells were transfected with the indicated 
siRNAs and infected with RVFV (MOI 0.3, 18h), then processed for RVFV Gn glycoprotein 
immunoblot. A representative blot is shown (n≥3). 
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Figure 9: Human MTR4 and 
ZCCHC7 are exported to the 
cytoplasm upon viral 
infection. (A) U2OS cells were 
infected with RVFV (MOI 10, 
12h) or mock infected and 
processed for 
immunofluorescence 
microscopy for hZCCHC7 
(green), RVFV N (red), and 
nuclei (blue). (B) Quantification 
of the percentage of cells with 
cytoplasmic hZCCHC7 
punctae in mock- or RVFV-
infected cells in at least 3 
experiments as in A. 
Mean±SEM shown. *p<0.05 
compared to mock by 
Student’s t-test. (C) U2OS cells 
were infected with SINV-mKate 
(MOI 10, 5h) or mock infected 
and processed for 
immunofluorescence 
microscopy for hZCCHC7 
(green), mKate (red), and 
nuclei (blue). (D) Quantification 
of the percentage of cells with 
cytoplasmic hZCCHC7 
punctae in mock- or SINV-
infected cells in at least 3 
experiments as in C. 
Mean±SEM shown. *p<0.05 
compared to mock by 
Student’s t-test. (E) U2OS cells 
were infected with SINV-GFP or VSV-GFP (MOI 10, 8h) and subjected to nuclear/cytoplasmic 
fractionation and immunoblot and probed for the nuclear protein lamin and the cytoplasmic 
protein tubulin to verify extract purity along with hMTR4 and hZCCHC7. A representative blot is 
shown (n≥3). (F) U2OS cells were infected with RVFV (MOI 10, 12h), SINV-GFP (MOI 10, 8h), or 
VSV-GFP (MOI 10, 8h) and subjected to nuclear/cytoplasmic fractionation and immunoblot and 
probed for the nuclear protein lamin and the cytoplasmic protein tubulin to verify extract purity 
along with hZCCHC7 and hZCCHC8. A representative blot is shown (n≥3). (G) U2OS cells were 
infected with VSV-GFP (MOI 10, 8h), SINV-GFP (MOI 10, 8h), or RVFV (MOI 10, 12h) and 
whole-cell lysates were processed for immunoblot. A representative image is shown (n=2). (H) 
U2OS cells were transfected with siRNA specific to CRM1 or control and infected with RVFV 
(MOI 10, 12h), then subjected to nuclear/cytoplasmic fractionation and immunoblot and probed 
for the nuclear protein Lamin and the cytoplasmic protein tubulin to verify extract purity along with 
hMTR4 and hZCCHC7. A representative image is shown (n≥3). 
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Figure 10: Human ZCCHC7 localization can be assessed by immunofluorescence. (A) 
U2OS cells were transfected with the indicated siRNAs, then infected with RVFV (MOI 10, 12h) or 
mock infected and processed for immunofluorescence microscopy for hZCCHC7 (green), RVFV 
N (red), and nuclei (blue). (B) U2OS cells were infected with RVFV (MOI 10, 12h) or mock 
infected and processed for immunofluorescence microscopy for the indicated proteins. 
Monochrome images of cells in Fig 4A. (C) U2OS cells were infected with SINV-mKate (MOI 10, 
5h) or mock infected and processed for immunofluorescence microscopy for the indicated 
proteins. Monochrome images of cells in Fig 4C. (D) Mean±SEM of average number of punctae 
per infected cell with punctae from at least 3 experiments in B and C. (E) U2OS cells were 
infected with RVFV (MOI 10, 12h), SINV-mKate (MOI 10, 5h), or mock infected and processed for 
immunofluorescence microscopy for hZCCHC8 (green) and nuclei (blue). Representative images 
are shown (n=2). (F) U2OS cells were transfected with siRNA to CRM1 or control and samples 
were processed for immunoblot 72 h post transfection. A representative blot is shown (n=3). 
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Figure 11: Human MTR4 and ZCCHC7 form a cytoplasmic complex with the exosome upon 
infection. U2OS cells were transfected with an hMTR4-FLAG expression vector or empty vector 
and infected with RVFV (MOI 10, 12h) or mock-infected, then either (A) whole cell lysates or (B) 
cytoplasmic fractions were processed for co-immunoprecipitation. 4% input was loaded for 
hMTR4 immunoblot, 8% input for other proteins. Actin was used as a loading control. 
Representative blots shown (n≥3). 
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Figure 12: Human MTR4 and ZCCHC7 can be ectopically expressed. (A) U2OS cells were 
transfected with the indicated vectors, induced with doxycycline at 24 h, and infected with RVFV 
(MOI 10, 12h) at 48 h post-transfection. Nuclear/cytoplasmic fractionation was performed, and 
cytoplasmic fractions were subject to anti-FLAG immunoblot. A representative blot is shown 
(n=2). (B) Schematic of the RVFV S segment RNAs and PCR products produced during RNA 
immunoprecipitation. Forward primers are shown in green, reverse primers in red. N and Nss 
mRNA products also amplify genome and antigenome, but the genome/antigenome product does 
not amplify mRNAs. (C) U2OS cells were transfected with the indicated siRNAs and infected with 
RVFV (MOI 1, 12h). Infected cells were treated with cycloheximide (50 ug/ml) and processed for 
RT-qPCR at the indicated timepoints. Mean±SEM shown normalized to hDCP2 (n≥3). 
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Figure 13: Viral mRNA is bound by hZCCHC7. (A-B) U2OS cells were transfected with an 
hZCCHC7-FLAG expression vector or empty vector and infected with (A) RVFV (MOI 10, 12h) or 
(B) SINV-GFP (MOI 10, 8h), then fractionated. Cytoplasmic extracts were collected (input) and a 
fraction was subject to FLAG immunoprecipitation and processed for RT-qPCR. RNA 
quantification was normalized to vector control input or FLAG IP. Fold change in hZCCHC7-
bound RNA normalized to vector-bound RNA is presented. hDCP2 is used as an endogenous 
mRNA control as it is not known to be regulated during RVFV or SINV infection. Mean±SEM 
shown. *p<0.05 by Student’s t-test.  
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Figure 14: The RNA exosome and hZCCHC7 target viral mRNAs for decay. (A) U2OS cells 
were infected with RVFV (MOI 0.3, 18h) and 3’ RACE was performed using primers that detect 
the RVFV small segment RNAs indicated. Sequenced reads were aligned to RVFV and classified 
as full-length or shortened, and the percentage of sequencing reads to be classified as full length 
or slightly shortened (less than 5 nucleotides) was plotted. Pooled data from three biological 
replicates is shown. (B) Pie chart of N mRNA reads from A that are full length (blue), encode a full 
length ORF but truncated 3’ UTR (red), or that encode a truncated ORF are shown (green). (C) 
U2OS cells were transfected with the indicated siRNAs and infected with RVFV (MOI 1, 12h). 
Infected cells were treated with cycloheximide (50 µg/ml) and processed for RT-qPCR at the 
indicated timepoints. Mean±SEM shown normalized to hDCP2 (n≥3). *p<0.05 compared to 
control by Student’s t-test. (D) U2OS cells stably expressing cGFP reporters with the indicated 3’ 
UTRs were transfected with siRNAs targeting hRRP6 and hDIS3 or control and either uninfected 
or infected with RVFV (MOI 10, 18h). Cells were subsequently processed for automated 
immunofluorescence microscopy. Mean±SEM shown normalized to mock-infected control (n≥3). 
*p<0.05 compared to control by Student’s t-test. A-B in collaboration with Sanjay Menghani. D in 
collaboration with Jeremy Wilusz. 
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Figure 15: A cGFP reporter with the RVFV NSs 3’ UTR can be expressed. (A) Schematic of 
the cGFP RVFV NSs-3’ UTR reporter. A cGFP ORF is expressed with a downstream RVFV NSs 
3’ UTR and mascRNA sequence. RNase P cleavage generates a mature mRNA with the 
appropriate 3’ UTR as well as a mascRNA. (B) U2OS cells were transfected with the indicated 
vectors and processed for cGFP northern blot 24 h later. Actin is used as a loading control (C) 
U2OS cells were transfected as in A and processed for mascRNA small RNA northern blot 24 h 
later. U6 is used as a loading control. (D) U2OS cells were transfected as in A and processed for 
automated immunofluorescence microscopy for cGFP (green) and nuclei (blue). A-D in 
collaboration with Jeremy Wilusz. 
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III. PKR SENSING OF VIRAL RNA DURING SINV INFECTION RECRUITS ZCCHC7 
TO STRESS GRANULES AND EXOSOME GRANULES 
Introduction 
Infection with RNA viruses disturbs the normal intracellular milieu, changing the molecular 
landscape through the production of viral nucleic acids and proteins. These pathogen-associated 
molecular patterns (PAMPs) are detected by a series of dedicated sensors which signal 
transcription and activation of antiviral effecotrs and further sensors (Mogensen 2009).These 
sensors include the Toll-like receptors (TLRs), which detect viral glycoproteins or viral RNA on 
the cell surface or in endosomes as an early system for viral detection (Jensen and Thomsen 
2012). Once viruses enter the cytoplasm and begin replication, they produce virus-specific RNAs 
such as dsRNAs or uncapped RNAs with 5’ triphosphates (Moon and Wilusz 2013). These 
abnormal RNA motifs are detected by a variety of cytoplasmic sensors such as the helicases 
RIG-I and MDA5, as well as the dsRNA-activated kinase PKR (Clemens et al. 1993; Williams 
1995; Balachandran et al. 2000; Kato et al. 2006; Kato et al. 2008). Detection of viral molecules 
through these sensors leads to diverse effects such as induction of the interferon response, 
translational shutdown to combat production of viral proteins, and apoptosis to prevent the spread 
of viral infection (Roberts et al. 1976; Castelli et al. 1997; Sadler and Williams 2008; Brennan-
Laun et al. 2014). 
In addition to the dedicated sensors, many members of the RNA metabolic machinery have 
acquired additional antiviral roles, identifying foreign viral RNA motifs and potentially targeting 
them for degradation (Moon et al. 2012b; Moy et al. 2014a). In particular, we recently found that 
components of the RNA exosome complex and its cofactor complex TRAMP, which degrade 
RNA 3’ to 5’, are antiviral against the diverse RNA viruses vesicular stomatitis virus (VSV), Rift 
Valley fever virus (RVFV), and Sindbis virus (SINV) (Molleston et al. 2016). Furthermore, the 
antiviral components of the TRAMP complex, hMTR4 and hZCCHC7, are exported from their 
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normal localization in the nucleolus to the cytoplasm in response to viral infection. There, 
hZCCHC7 specifically identifies viral mRNAs and targets them for exosomal degradation. Though 
we do not yet understand the signals which lead to TRAMP component export, we found that 
hZCCHC7 localizes to cytoplasmic punctae during viral infection, suggesting that it may be 
coregulated with ribonucleoprotein (RNP) granules. 
RNP granules are localized collections of RNA-processing proteins and their bound RNA targets 
which form in the cytoplasm in a coregulated fashion (Thomas et al. 2011). The most extensively 
characterized of these RNP granules are stress granules, which form in response to a variety of 
stressors such as temperature shock or oxidative stress (Protter and Parker 2016). They are 
largely comprised of stalled initiation complexes on their bound mRNAs, as well as RNA-binding 
chaperones thought to remove regulated RNAs from translation and protect RNAs from damage 
during periods of stress. In addition to sequestering RNAs, stress granules are capable of 
passing stalled RNAs to other RNP structures such as processing bodies (P-bodies), which are 
composed of RNAs targeted for degradation as well as decapping and 5’ to 3’ decay enzymes 
(Kedersha et al. 2005). 
Stress granules are also increasingly recognized as a component of the intrinsic immune 
response to viral infection. During infection, activation of PKR by viral RNA leads to the 
phosphorylation of the initiation factor eIF2α which stalls translation, blocking synthesis of new 
viral and host proteins and triggering the rapid accumulation of stress granules (Kedersha et al. 
1999; Lindquist et al. 2011; Okonski and Samuel 2013). Stress granule formation has been 
shown for a variety of viruses, including Newcastle disease virus, encephalomyocarditis virus, 
influenza A virus, poliovirus, and SINV (Ng et al. 2013). In infection with several of these viruses, 
including SINV, these stress granules have also been shown to recruit RNA sensors and 
effectors such as RIG-I and RNASEL, which is believed to concentrate these proteins and their 
viral RNA targets together to better antagonize viral infection (Onomoto et al. 2012).  
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A third type of RNP granule, exosome granules, are much less well-characterized than P-bodies 
or stress granules. These granules are composed of structural components of the 3’ to 5’ RNA 
exosome complex as well as RNAs targeted for exosomal decay such as those containing AU-
rich elements (Lin et al. 2007; Zurla et al. 2011). An emerging literature has linked a variety of 
antiviral RNA-binding proteins to the exosome, which potentially serves as a convergent effector 
of many sensors (Guo et al. 2007; Miyashita et al. 2011; Liang et al. 2015). As we demonstrated 
that hMTR4 and hZCCHC7 bind to the exosome in the cytoplasm during viral infection, it is likely 
that they colocalize with exosome granules (Molleston et al. 2016). However, the sensing 
pathways necessary for this protein movement are unknown, and whether these punctae 
represent exosome granules, stress granules, P-bodies, or unique structures has also yet to be 
determined.  
In this study, we tested the hypothesis that the movement of hZCCHC7 is coregulated with the 
formation of known RNP granules in response to SINV infection. We determined that dsRNA, a 
known trigger for stress granule formation, is both necessary and sufficient to induce cytoplasmic 
hZCCHC7 punctae. We screened key innate immune signaling adaptors and sensors for their 
effects on hZCCHC7 movement and found that formation of hZCCHC7 punctae is PKR-
dependent. Finally, we imaged components of the three major classes of RNP granules and 
found that hZCCHC7 granules colocalize with both exosome granules and stress granules, but 
not P-bodies, during SINV infection. Overall, we propose that PKR sensing of dsRNA during viral 
replication recruits the normally nucleolar hZCCHC7 to both stress granules and exosome 
granules, allowing it to sense translationally-stalled viral RNA and bring it to the exosome for 
degradation. 
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Results 
Double-stranded RNA is sufficient to induce formation of cytoplasmic hZCCHC7 granules 
We previously demonstrated that infection with SINV leads to the relocalization of components of 
the RNA exosome cofactor complex TRAMP, including hZCCHC7, from their normal localization 
in the nucleolus to the cytoplasm, where they form cytoplasmic punctae (Molleston et al. 2016). 
We found that this relocalization is activated by diverse viruses including VSV and RVFV. Since a 
major PAMP formed during replication of these diverse RNA viruses is dsRNA, we tested whether 
dsRNA is sufficient to induce this relocalization. To differentiate between effects mediated by the 
endosomal dsRNA sensor TLR3 and the cytosolic sensors such as RIG-I, MDA5, and PKR, we 
either added the synthetic dsRNA polyinosinic-polycytidylic acid (poly(I:C)) to the extracellular 
media or transfected it into the cytoplasm of cells (Kato et al. 2008; Barbalat et al. 2011; Laredj 
and Beard 2011). Cells were treated for 8 hours, after which immunofluorescence was performed 
for hZCCHC7 (Figure 16A,B). Extracellular treatment with poly(I:C) did not induce movement of 
hZCCHC7 to the cytoplasm, suggesting that RNA sensing by endosomal sensors is not sufficient 
for export. However, transfection of poly(I:C) induced formation of cytoplasmic hZCCHC7 punctae 
in a majority of transfected cells, suggesting that the presence of dsRNA in the cytoplasm is 
sufficient to induce export of hZCCHC7.  
UV inactivated SINV cannot induce the formation of hZCCHC7 granules 
Cytoplasmic sensors of dsRNA, such as RIG-I, MDA5, and PKR, require replication of RNA 
viruses in order to generate the dsRNA intermediates which they target (Triantafilou et al. ; da 
Conceição et al. 2013; Nikonov et al. 2013). Thus, infection with UV-inactivated viruses, which 
cannot replicate, does not activate these sensors, allowing differentiation between viral sensing 
through these pathways and replication-independent pathways. Therefore, we infected human 
U2OS cells with either live or UV-inactivated SINV. Cells were fixed and immunofluorescence 
was performed for hZCCHC7 and viral antigens (Figure 16C). We found that live SINV induced 
cytoplasmic hZCCHC7 punctae as previously published (Molleston et al. 2016). However, UV-
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inactivated SINV did not, suggesting that viral replication is required for detection and export of 
hZCCHC7. 
PKR is necessary for efficient hZCCHC7 export in response to SINV infection 
Most TLR-mediated viral sensing requires the adaptors MyD88 or TRIF, while cytosolic RNA 
sensing by RIG-I and MDA5 requires the adaptor MAVS. PKR also detects cytosolic dsRNA. 
Therefore, we set out to determine whether any of these pathways were required for SINV-
induced hZCCHC7 relocalization. To this end, we transfected U2OS cells with siRNAs targeting 
PKR, MAVS, or a combination of MyD88 and TRIF. Three days later we infected the cells with 
SINV and performed immunofluorescence to detect hZCCHC7 and viral infection (Figure 17A). 
We used image analysis to quantify the number of cells with  cytoplasmic hZCCHC7 punctae and 
found that hZCCHC7 cytoplasmic accumulation in response to SINV infection is dependent on 
the cytosolic dsRNA sensor PKR (Figure 17B). This is consistent with our observation that 
hZCCHC7 export can be induced by poly(I:C) transfection and requires replication-competent 
SINV since PKR can be activated by poly(I:C) or SINV and requires viral replication for induction 
(Burke et al. 2009; Zhang et al. 2014). 
ZCCHC7-containing granules can colocalize with exosome granules and stress granules  
Previous work demonstrated that stress granules form during SINV infection in a PKR-dependent 
manner (Onomoto et al. 2012; Ng et al. 2013). Given the PKR-dependence of hZCCHC7 
relocalization and its role as an antiviral sensor, we hypothesized that hZCCHC7 punctae may 
colocalize with stress granules during SINV infection. Therefore, we performed 
immunofluorescence for hZCCHC7 and the stress granule component TIAR in SINV or mock-
infected U2OS cells (Figure 18A). We found that, as previously demonstrated, SINV infection 
induced the formation of TIAR-containing stress granules. Furthermore, these granules 
colocalized with hZCCHC7 (Figure 18D) suggesting that hZCCHC7 is recruited to stress granules 
during viral infection. 
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We previously found that hZCCHC7 co-immunoprecipitates with the exosome in the cytoplasm 
during infection (Molleston et al. 2016). Recent studies have suggested that  exosome structural 
components such as hRRP41 accumulate in exosome granules that are distinct from stress 
granules (Sheth and Parker 2003; Graham et al. 2006; Lin et al. 2007). Therefore, we also tested 
whether SINV-induced hZCCHC7 co-localized with exosome granules. To this end, we performed 
immunofluorescence for hZCCHC7 and hRRP41 in U2OS cells infected with SINV or mock-
infected (Figure 18B). We found that hRRP41 formed granules in SINV-infected cells, and that 
these granules colocalized with hZCCHC7-containing granules (Figure 18D).   
A third major RNA granule are P-bodies. While P-bodies are also known to be modulated by viral 
infection (Reineke and Lloyd 2013; Hopkins et al. 2015) we observed that SINV infection does not 
lead to the formation of P-bodies during infection as measured by GW182 accumulation (Figure 
18C). Altogether, these data suggest that virus-induced cytoplasmic hZCCHC7 granules localize 
to stress and exosome granules, but remain distinct from P-bodies. 
 
Discussion 
An emerging literature has identified a variety of antiviral RNA-binding proteins which relocalize 
from the nucleus to the cytoplasm during infection with cytoplasmic viruses (Moy et al. 2014a; 
Shapiro et al. 2014). In this study, we focused on the antiviral RNA binding protein hZCCHC7, an 
exosome cofactor of the TRAMP complex, which is exported to the cytoplasm during infection 
with several families of RNA viruses to restrict viral replication by targeting viral mRNA for decay 
(Molleston et al. 2016).  
We first investigated the viral stimuli necessary for hZCCHC7 relocalization. Since RNA viruses 
are largely sensed by their nucleic acids, we hypothesized that viral RNA would likely be the 
pathogen-associated molecular pattern (PAMP) detected by infected cells. Indeed, we found that 
transfection of the synthetic immunostimulatory dsRNA poly(I:C) induced the formation of 
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cytoplasmic hZCCHC7 punctae. As SINV is a positive-sense signle-stranded RNA virus, the 
incoming viral RNA is not thought to be double stranded (Strauss and Strauss 1994). Rather, viral 
replication by the RNA dependent RNA polymerase produces viral dsRNA intermediates. 
Therefore, we tested whether UV-inactivated virus could induce the formation of punctae and 
found that UV-inactivated SINV could not induce the formation of hZCCHC7 punctae, 
demonstrating that viral replication is required.  
Viral dsRNA is a known PAMP detected by a wide variety of sensors including TLR3, RIG-I, 
MDA5, and PKR (Barbalat et al. 2011). We tested the requirements for these sensors and their 
adaptors and found that SINV-induced hZCCHC7 relocalization was PKR-dependent. This is 
consistent with prior studies, which have shown that SINV can be detected by PKR (Burke et al. 
2009). Furthermore, PKR signaling is known to depend on the presence of dsRNA during viral 
infection; UV-inactivated viruses cannot activate PKR, while poly(I:C) can (Zhang et al. 2014).Our 
findings suggest the presence of a two-sensor system for detection of viral infection in which 
sensing by PKR triggers export of hZCCHC7 which in turn targets viral RNA for exosomal 
degradation. This functionally parallels the two-sensor system of oligoadenylate synthase, which 
is also activated by viral dsRNA, triggering the activation of RNASEL, which degrades viral and 
cellular RNAs (Silverman 2007; Barbalat et al. 2011). The addition of hZCCHC7 to the list of 
antiviral effectors regulated in response to dsRNA further underlines the importance of this PAMP 
in recruiting RNA-specific antiviral effectors. 
Since SINV is known to be detected by PKR and induce the formation of stress granules, we 
hypothesized that PKR-induced cytoplasmic hZCCHC7 would be recruited to stress granules. 
Therefore, we tested hZCCHC7 colocalization with markers of multiple types of RNP granules 
and found that SINV-induced hZCCHC7 granules colocalize with both exosome granules and 
stress granules. PKR-induced stress granules, known as “antiviral stress granules”, have 
previously been characterized as induced by a wide range of viruses including SINV (Onomoto et 
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al. 2012; Ng et al. 2013). These findings suggest that during SINV infection, hZCCHC7 is 
recruited to antiviral stress granules, which are known to recruit other antiviral RNA-binding 
proteins such as RIG-I and RNASEL. We hypothesize that focusing multiple antiviral sensors and 
effectors in one compartment is beneficial to the infected host and potentiates antiviral defense 
(Onomoto et al. 2014).  
Our finding that virus-induced exosome granules and stress granules coalesce with ZCCHC7 
demonstrates the flexibility of these RNP granules and furthermore suggests the possibility that 
stress and exosome granules may interact with each other. Stress granules have been previously 
observed to interact with p-bodies to pass RNAs to the 5’ degradation machinery, and it has been 
suggested that mRNAs targeted to stress granules are also targeted to exosome granules, 
implying some overlap between stress granules and 3’ degradation (Kedersha et al. 2005; Zurla 
et al. 2011). However, this work represents the first example of exosome cofactor proteins 
colocalizing with stress granule components. We hypothesize that infection-induced relocalization 
of hZCCHC7 causes retargeting of the RNA exosome to viral RNA in many locations, including 
stress granules, but it remains to be seen whether viral infection induces direct interaction 
between exosome and stress granules. 
Overall, we have identified a new pathway by which detection of replicating SINV RNA by PKR 
leads to recruitment of nucleolar hZCCHC7 to RNP granules which have characteristics of both 
exosome granules and stress granules. These findings suggest that innate immunity is intimately 
associated with the RNA decay machinery and future studies will seek to further develop this 
important connection.  
Materials and Methods 
Cells, viruses, antibodies, and reagents 
Human U2OS cells were grown and maintained as previously described (Moser et al. 2012). 
SINV-mKate (gift from M. Heise) was grown in C636 cells as described (Burnham et al. 2007).  
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Viral titers were calculated by plaque assay on BHK cells. Antibodies to hZCCHC7 were obtained 
from Sigma. Antibodies to hRRP41 were acquired from Santa Cruz. Antibodies to GW182 were 
acquired from Abcam. Antibodies to TIAR were acquired from BD. Fluorescent secondary 
antibodies were obtained from Invitrogen, and HRP-conjugated antibodies were from Amersham. 
Other chemicals were purchased from Sigma. 
Mammalian RNAi 
Ambion Silencer Select siRNAs were used for PKR, GE Dharmacon On-Target siRNAs were 
used for MAVS, MyD88, and TRIF. Transfection into U2OS cells was performed using HiPerFect 
(Qiagen) as per the manufacturer’s protocol. Cells were incubated for 3 days. Silencer Select 
Negative Control #2 (Ambion) was used as a non-targeting control. 
Viral infections 
Three days post-RNAi, cells were infected with the indicated viruses. U2OS cells were infected 
with SINV-mKate (MOI = 10) for 5 hours. 
Immunofluorescence 
U2OS cells grown on coverslips were imaged with a Leica DMI 4000 B fluorescent microscope. 
MetaXpress software was used to quantify cytoplasmic hZCCHC7 punctae between .8 and 2 µm 
in size in mock infected and infected or transfected cells (infection was verified by 
immunofluorescence for each cell to be quantified) with at least 25 cells quantified per condition. 
All experiments were performed at least three times. 
Transfection of polyinosinic-polycytidylic acid 
Polyinosinic-polycytidylic acid (poly(I:C)) was transfected using Lipofectamine 2000 reagent 
(Thermo Fisher) according to the manufacturer’s protocol. Cells were plated on coverslips in 24-
well cell culture plates (40,000 cells/well). Five µg of poly(I:C) was transfected 24 hours after cell 
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plating, and media was changed 3 hours after transfection. Eight hours after transfection, cells 
were fixed and processed for immunofluorescence. 
UV-inactivation of viruses 
SINV-mKate and RVFV viral stocks were inactivated by treatment with 2 million microjoules of UV 
radiation in a UV Stratalinker 2400 hybridization oven. Viral infection was performed at a 
theoretical MOI of 25 for 5 hours (SINV) or 12 hours (RVFV) with parallel infection of live virus. 
Inactivation of viral replication was confirmed by loss of immunofluorescence signal compared to 
live virus.  
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Figure 16: Export of hZCCHC7 to the cytoplasm requires replication of viral RNA. (A) U2OS 
cells were treated with poly(I:C) by transfection or extracellular addition to media for 8h and 
processed for immunofluorescence microscopy for hZCCHC7 (green) and nuclei (blue). (B) 
Quantification of the percentage of cells with cytoplasmic hZCCHC7 punctae in at least 3 
experiments as in A. Mean±SEM shown. *p<0.05 compared to mock by Student’s t-test. (C) 
U2OS cells were infected with live or UV-inactivated SINV-mKate (MOI 25, 5h) or mock infected 
and processed for immunofluorescence for hZCCHC7 (green) and nuclei (blue). Representative 
images of at least 3 experiments are shown. 
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Figure 17: SINV-induced export of hZCCHC7 is PKR-dependent. (A) U2OS cells were 
transfected with the indicated siRNAs and infected with SINV-mKate (MOI 10, 5h) or mock 
infected and processed for immunofluorescence microscopy for hZCCHC7 (green), mKate (red), 
and nuclei (blue). (B) Quantification of the percentage of cells with cytoplasmic hZCCHC7 
punctae in mock- or SINV-infected cells in at least 3 experiments as in A. Mean±SEM shown. 
*p<0.05 compared to mock by Student’s t-test. 
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Figure 18: SINV-induced hZCCHC7 granules colocalize with exosome and stress granules. 
U2OS cells were infected with SINV-mKate (MOI 10, 5h) and processed for immunofluorescence 
for hZCCHC7 (green), nuclei (blue) or (A) TIAR, (B) hRRP41, or (C) GW182 (red). 
Representative images of at least 3 experiments are shown. (D) Quantification of the percentage 
of hZCCHC7 punctae which colocalize with hRRP41 or TIAR in SINV-infected cells in at least 3 
experiments as in A and B. Mean±SEM shown.  
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IV. CONCLUDING REMARKS 
Summary 
The RNA processing machinery interacts with nearly every facet of cellular biology. In addition to 
its canonical cellular roles, it is increasingly recognized as one of the most ancient responses to 
RNA virus infection. RNA silencing, the 5’ cap binding complex, the 5’ decay machinery, and 
myriad RNA helicases have all been shown to double as antiviral effectors. However, the full 
cohort of antiviral proteins among the RNA processing machinery is not fully characterized. It is 
likely that additional roles exist in restriction of viral infection across virus families for previously 
identified RNA-binding proteins. To discover new roles for genes involved in RNA biology, we 
performed an RNAi screen to identify those with antiviral effects against the disparate 
arboviruses, vesicular stomatitis virus (VSV) and Sindbis virus (SINV). 
The exosome as a conserved antiviral effector 
Our screen identified 26 genes with antiviral effects against both VSV and SINV, including Ars2 
and two components of the nuclear cap-binding complex (CBC20 and CBC80) which we had 
previously characterized as broadly antiviral (Sabin et al. 2009). In addition, several genes active 
at the 3’ end of mRNA were identified; these include hiiragi, a poly(A) polymerase, as well as 
CG7185, the probable Drosophila ortholog of CPSF6, a cleavage and polyadenylation factor 
(Sabin et al. 2009; Sabath et al. 2013). Of particular interest to us was the identification of dRrp6, 
one of the key 3’ to 5’ exonucleases in the RNA exosome complex, and the only exosome 
component in the screening panel. In a previous genome-wide RNAi screen using Rift Valley 
fever virus (RVFV), we found the other exosomal exonuclease, dDis3, to be antiviral (Hopkins et 
al. 2013). The combination of multiple exosome genes identified as antiviral in screens against 
diverse RNA viruses suggested a broad role for the exosome complex as a whole. Thus, we 
tested the exonucleases dRrp6 and dDis3 as well as the exosome structural components dRrp4 
and dRrp41 against VSV, SINV, and RVFV, and found that each of these genes is antiviral 
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against all three viruses tested. Furthermore, we found that the antiviral effects of these genes 
are conserved from flies into human cells. 
The exosome has long been suggested to play an antiviral role in diverse organisms including 
humans and yeast. Several of the exosome core and cofactor genes were first identified due to 
the “superkiller” phenotype, in which yeast strains mutant in exosome core or cofactor genes 
were killed far more efficiently by dsRNA viruses (Masison et al. 1995; Anderson and Parker 
1998; Benard et al. 1998). At the time this was attributed to translational rather than RNA stability 
effects. However, in light of the subsequent characterization of the RNA exosome complex, it is 
likely that degradation of viral RNA plays a role in controlling yeast viruses. In human cells, 
several different RNA-binding proteins with antiviral activity, such as ZAP, DDX60, and AID, were 
found to bind to exosome components (Guo et al. 2007; Miyashita et al. 2011; Liang et al. 2015). 
However, the studies characterizing these interactions did not independently identify effects of 
exosome depletion on viral replication. I hypothesize that an antiviral role for the exosome was 
not previously observed due to the incomplete depletion of these genes by RNAi in human cells, 
resulting in only modest effects on viral replication. In Drosophila, dsRNA more efficiently 
depletes targets, resulting in substantially more pronounced effects of exosome depletion on viral 
RNA. Furthermore, the strongest antiviral effects on viral RNA in Drosophila were from the 
exosome exonucleases, the original antiviral hits from our screens. These exonucleases have not 
been studied in the context of viral infection previously. Rather, all prior studies instead focused 
on the structural components of the exosome which have a less pronounced antiviral phenotype. 
By screening components of the known exosome cofactor complexes Ski, TRAMP, and NEXT, I 
was able to determine that two components of the TRAMP complex, dMtr4 and dZcchc7, were 
antiviral against all viruses tested. However, neither the TRAMP-associated poly(A) polymerase 
dTrf4-1, nor the Ski and NEXT complexes had this activity. Furthermore, I found that the antiviral 
roles of Mtr4 and Zcchc7 are conserved in their human orthologs, hMTR4 and hZCCHC7. In the 
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case of Mtr4, the conserved antiviral role between humans and Drosophila is not surprising given 
the high level of amino acid conservation; the protein has approximately 67% identity between 
these two species, and 51% identity between humans and yeast (Houseley and Tollervey 2008). 
However, Zcchc7 is not nearly as conserved; the yeast Zcchc7 ortholog, Air2, is only 34% 
identical to hZCCHC7 in the zinc finger region, with no homology elsewhere in the protein. 
Similarly, hZCCHC7 is only 33% identical to dZcchc7 in the zinc finger region and completely 
dissimilar elsewhere, suggesting that Zcchc7/Air is divergent across species. While Mtr4 has 
been found to have a role in processing of the 5.8s rRNA in both yeast and humans, the only 
identified RNA to be targeted by the other TRAMP components in humans is the 5’ ETS spacer 
remaining during rRNA processing (de la Cruz et al. 1998; Shcherbik et al. 2010; Lubas et al. 
2011). Most other yeast TRAMP roles have been taken over by the human NEXT complex, which 
shares hMTR4 with TRAMP. In light of my new findings, it seems that the loss of other important 
roles for Zcchc7 in animals has permitted it to develop new targeting specificities which include 
viral RNA. It is clear that despite continued sequence divergence between Drosophila and 
humans, Zcchc7 has retained enough functional conservation to have broad antiviral roles in both 
species. 
It is surprising that no components of the Ski complex were antiviral against any of the viruses 
tested, given that the first discovered role for the yeast Ski genes was in restriction of dsRNA 
yeast viruses (Toh-E et al. 1978). Furthermore, the use of a cytoplasmic cofactor complex in 
restriction of cytoplasmic RNA viruses is much simpler than movement of a nucleolar complex 
into the cytoplasm. There are several potential reasons why the Ski complex is not antiviral. 
Firstly, it may not be involved in degradation of viral RNA even in yeast; despite later being found 
to be exosome cofactors, the yeast Ski genes were not found to affect degradation rates of viral 
RNA, rather antagonizing viral replication at the level of translation (Masison et al. 1995). 
Secondly, it is possible that viruses have developed evasion or antagonism strategies to the Ski 
complex due to its presence in the cytoplasmic compartment across kingdoms. Both RVFV and 
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SINV are known to make accessory proteins which induce degradation or inhibit transcription of 
antiviral factors, so they may have found a way to antagonize Ski, necessitating the repurposing 
of TRAMP to the cytoplasm as a new antiviral weapon (Bouloy et al. 2001; Frolova et al. 2002; 
Billecocq et al. 2004; Gorchakov et al. 2004; Garmashova et al. 2006; Ikegami et al. 2009). 
Finally, it is possible that Ski has an antiviral role which is obscured by its additional regulatory 
roles; the human Ski helicase SKI2L was recently found to downregulate interferon production to 
prevent autoimmunity, and though Drosophila lacks interferon, it is possible that dSki2 has 
regulatory roles in flies as well (Eckard et al. 2014). If depletion of Ski genes results in 
overproduction of antiviral factors such as interferon, the effect on viral replication may not be 
predictable, obfuscating the many potential roles of the Ski complex.   
The regulation of TRAMP component export 
Due to the broad antiviral role of the RNA exosome and TRAMP cofactor components in human 
cells, I hypothesized that the RNA-binding TRAMP components target viral RNA for exosomal 
degradation. However, VSV, SINV, and RVFV all replicate in the cytoplasm, while the TRAMP 
components are restricted to the nucleus. Thus, a direct antiviral role would require relocalization 
of these components to the cytoplasm. Interestingly, precedent exists for this type of intracellular 
movement in response to infection; an increasing number of nuclear RNA-processing proteins 
have been identified which move to the cytoplasm to target viral RNA. The pri-miRNA-processing 
nuclease Drosha is exported to the cytoplasm in response to infection with diverse arboviruses or 
treatment with the synthetic dsRNA poly(I:C) and mediates an antiviral response (Shapiro et al. 
2014). In addition, the splicing and transcriptional regulator DDX17 moves to the cytoplasm 
during bunyavirus infection and binds bunyavirus RNA to restrict viral replication (Moy et al. 
2014a). Consistent with the behavior of these other nuclear antiviral RNA-binding proteins, I 
found that the canonically nucleolar hMTR4 and hZCCHC7 are exported to the cytoplasm during 
infection with VSV, SINV, or RVFV. Furthermore, hZCCHC7 forms cytoplasmic granules during 
viral infection that can colocalize with stress granules and exosome granules. 
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I investigated the sensing mechanisms responsible for the relocalization of these proteins and 
found that transfection with poly(I:C) was sufficient to trigger protein export from the nucleus. 
Consistent with this, the dsRNA-sensitive kinase PKR, which is known to respond to both SINV 
and poly(I:C), was necessary for hZCCHC7 movement during SINV infection. As with Drosha, the 
antiviral TRAMP components move in response to a variety of viral signals in addition to poly(I:C), 
suggesting the possibility that the export of these proteins is regulated in the same way. Though 
RVFV also induces hZCCHC7 movement to cytoplasmic punctae, it is likely not regulated in the 
same way; RVFV induces PKR degradation during viral infection and prevents the formation of 
PKR-dependent granules such as stress granules, making it likely that it is sensed in another way 
to induce hZCCHC7 granules (Ikegami et al. 2009; Hopkins et al. 2015; Kainulainen et al. 2016). 
In order to determine whether viral replication is necessary for cellular sensing and subsequent 
export of TRAMP components, I infected cells with UV-inactivated or live virus and found that UV-
inactivated virus could not induce hZCCHC7 relocalization to the cytoplasm. This finding is 
consistent with PKR as the sensor; PKR is activated by dsRNA intermediates which form during 
viral infection thus requires viral replication (Burke et al. 2009; Zhang et al. 2014).  
A cytoplasmic TRAMP-like complex 
In order to function as cofactors for the exosome, RNA-binding proteins must interact with 
exosome proteins to deliver targeted RNA for degradation. In their canonical nucleolar roles, the 
TRAMP components hMTR4 and hZCCHC7 interact with the exosome exonuclease hRRP6, 
which is itself both nuclear and cytoplasmic (Tomecki et al. 2010; Lubas et al. 2011). In order to 
target viral RNA for degradation, I hypothesized that hMTR4 and hZCCCH7 would interact with 
hRRP6 as well as viral RNA in the cytoplasm. Indeed, I was able to find that hMTR4 
immunoprecipitates with hRRP6 and hZCCHC7 in cytoplasmic fractions only during virus 
infection, suggesting the formation of an infection-dependent cytoplasmic complex in addition to 
the canonical nucleolar TRAMP complex. Furthermore, cytoplasmic hZCCHC7 specifically binds 
viral mRNA, suggesting that this cytoplasmic complex of TRAMP components targets viral RNA 
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for degradation. This interaction between RNA-binding antiviral proteins and components of the 
exosome is an emerging theme in the literature. For example, ZAP, DDX60, and AID have all 
been shown to bind exosome components, though none of them demonstrated an infection-
dependent complex (Guo et al. 2007; Miyashita et al. 2011; Liang et al. 2015). Furthermore, all of 
these proteins have been found to bind viral RNA, as hZCCHC7 does. I hypothesize that these 
RNA-binding proteins serve as sensors for different classes of viruses which all converge on the 
RNA exosome for their effector function. It is likely that these antiviral sensors have some 
synergistic roles as well; DDX17 binds bunyaviral RNA and immunoprecipitates with both ZAP 
and hMTR4, suggesting the possibility that sensors of different viral RNA motifs may physically 
group together to recruit the exosome (Chen et al. 2008; Lubas et al. 2011; Moy et al. 2014a). 
This cytoplasmic complex of TRAMP components and the exosome likely operates independently 
of the canonical TRAMP complex. In the nuclear and nucleolar roles of TRAMP, the poly(A) 
polymerase Trf4 adds 5-6 adenines to RNAs targeted for exosomal degradation (Egecioglu et al. 
2006). My 3’ RACE analysis revealed no evidence of untemplated oligoadenlyation on any RVFV 
RNAs. Combined with our verification that the TRAMP poly(A) polymerase dTrf4-1 is not antiviral, 
these data suggest that the role for the TRAMP components in RVFV infection is distinct from 
that of canonical TRAMP. Oligoadenylation of RNA targets is believed to have evolved to create a 
“launching pad” of unstructured RNA to permit degradation of heavily structured targets such as 
tRNAs, and is dispensable for many other targets (Paolo et al. 2009). Viral RNAs, which are less 
structured than tRNAs, likely do not require adenylation for exosomal degradation. 
Recent evidence has demonstrated roles for Mtr4 in a variety of “TRAMP-like” complexes 
independent of the Trf4 polymerase. In yeast, Mtr4 has been shown to interact with different 
RNA-binding adaptor proteins to process distinct rRNA targets (Thoms et al. 2015). Human 
MTR4 forms both the nucleolar TRAMP and nucleoplasmic NEXT complexes (Lubas et al. 2011). 
Given that Mtr4 exists as part of several distinct and co-occuring complexes, it has been 
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suggested that these complexes, such as NEXT, should be named to reflect their protein 
composition and localization as compared to canonical TRAMP. Therefore, I propose that the 
cytoplasmic complex I describe be called the VICE (Virus-Induced Cytoplasmic Exosome) 
complex. 
Viral RNAs as RNA regulons 
Classes of mRNAs such as immune mediators are tightly regulated together in groups called 
RNA regulons. These regulons contain sequences in the 3’ UTR, such as AU-rich elements or C-
rich motifs, that are recognized by RNA-binding proteins, leading to up- or down-regulation of 
these RNAs by altering their susceptibility to degradation machinery including the exosome (Chen 
et al. 2001; Mukherjee et al. 2002; Keene 2007; Singer et al. 2012; Blackinton and Keene 2014). 
As the exosome degrades several classes of mRNAs based on signals in their 3’ UTR’s, I 
hypothesized that the 3’ UTR of RVFV is the RNA sequence which recruits the exosome for 
degradation, and used a cGFP-3’UTR reporter system to test this hypothesis. I found that 
expression of the RVFV NSs 3’ UTR downstream of the cGFP ORF was sufficient to induce 
exosome-dependent reduction of cGFP expression during RVFV infection. A similar construct 
with an SV40 polyadenylation signal was not affected by RVFV infection nor exosome depletion, 
suggesting that the effect of the exosome on the NSs 3’ UTR is specific and not merely a 
byproduct of normal exosome-mediated mRNA turnover. The requirement of viral infection for 
exosome-dependent restriction of a viral 3’ UTR suggests that this recognition is regulated. We 
previously found that RVFV infection induced 5’ degradation of mRNAs containing 5’ terminal 
oligopyrimidine tracts (Hopkins et al. 2015). Just as these endogenous mRNAs are subject to 
degradation during RVFV infection, it is possible that changes such as the movement of 
hZCCHC7 and hMTR4 induce restriction of exogenous viral mRNAs by recognition of their 3’ 
UTRs. This apparent viral RNA regulon could in fact be just one example of a larger group of 
mRNAs regulated during viral infection by the VICE complex. 
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Though I have demonstrated binding of RVFV and SINV mRNA by hZCCHC7, the specific viral 
RNA sequence within the 3’ UTR necessary for binding remains unknown. RNA viruses 
frequently have higher order structures such as stem loops. Our lab and others have previously 
identified several of these structures in the 3’ UTRs of RVFV (Ikegami et al. 2007; Moy et al. 
2014a). Alternatively, RVFV mRNAs, which are not polyadenylated, may be recognized by 
cytoplasmic TRAMP components in the VICE complex due to their missing poly-A tails. This 
mirrors one of the nuclear roles of yeast TRAMP, wherein it degrades mRNA precursors which 
fail to polyadenylate (Milligan et al. 2005). It is likely that structural motifs rather than specific 
sequence motifs drive recognition of RVFV mRNAs, as the different mRNAs have 3’ UTRs which 
vary both in length and sequence composition, making one common sequence motif unlikely 
(Ikegami et al. 2007). 
Future directions 
While I have successfully characterized a virus-induced cytoplasmic exosome complex, much 
remains unclear about the induction, composition, and RNA target identification of this complex. 
Thus, I propose a range of future studies in these three broad areas to better understand both the 
regulation of exosomal targeting and the determinants of antiviral activity of this novel complex. 
Though I have found that manipulating PKR levels by siRNA affects hZCCHC7 export in 
response to SINV infection, a better understanding of the signaling is needed. First, my studies of 
sensors and adaptors only involved siRNA depletion. The creation of genetic mutant cells, 
perhaps using CRISPR, would allow me to assess whether hZCCHC7 movement can be 
completely abolished in the absence PKR, thus establishing it as necessary for viral sensing in 
this context. Furthermore, though it is unlikely that PKR senses RVFV infection, the sensor that 
drives hZCCHC7 export during RVFV is still unknown. Future studies should involve an siRNA 
screen of TLRs and RLRs assessing hZCCHC7 export by immunofluorescence or 
nuclear/cytoplasmic fractionation to determine which cellular sensors of viral infection are 
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responsible for this movement in RVFV infection. Identification of the sensor pathway involved will 
lead to a better understanding of the viral pathogen associated molecular pattern as well as its 
detection method. 
In addition to better characterization of events upstream of the sensors of virus infection, future 
studies should also explore the signal transduction downstream of the sensor. In addition to its 
canonical role in phosphorylation of eIF2α, PKR has been suggested to converge on the innate 
immune signaling cascade at the level of binding TRAF proteins and the IKK complex (Zamanian-
Daryoush et al. 2000; García et al. 2004; Mogensen 2009). Measuring the activation of each step 
in the pathway of PKR activation, both the canonical steps of autophosphorylation and 
phosphorylation of eIF2α as well as the putative PKR-involved innate immune pathways of 
phosphorylation of IKKβ and translocation of NF-κB to the nucleus, would demonstrate which 
signals downstream of PKR are activated by SINV infection, as well as providing a clue to the 
point of convergence between responses to SINV and RVFV infection. Furthermore, manipulation 
of these intermediaries through siRNA or genetic knockouts would allow me to demonstrate 
which signaling pathways are important for the export of TRAMP components. 
After signal transduction, a likely candidate for a direct molecular signal affecting TRAMP 
component localization is the small ubiquitin-like modifier (SUMO). SUMO is, like ubiquitin, a 
small protein which is covalently linked to lysines (Seeler and Dejean 2003; Gareau and Lima 
2010). Changes in SUMOylation of proteins affect protein function, stability, and localization, 
which is of particular relevance to hMTR4 and hZCCHC7. CRM1-mediated export of proteins 
such as TEL and p53 require that the proteins are SUMOylated as they are exported in order to 
be released from CRM1 into the cytoplasm (Wood et al. 2003; Santiago et al. 2013). 
Furthermore, patterns of SUMOylation are altered by the interferon response during viral 
infection, and increased SUMOylation of antiviral effectors is integral to deactivating inflammatory 
signals as viruses are cleared (Liu et al. 2013; Sahin et al. 2014; Decque et al. 2016). In light of 
these interactions, it is unsurprising that viruses such as IAV cause widespread changes in the 
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SUMOylation of transcription factors and other proteins (Domingues et al. 2015). ZCCHC7 has 
several putative SUMOylation sites identified by mass spectrometry, some of which are adjacent 
to computationally-predicted nuclear export and nucleolar localization signals (Hendriks et al. 
2014; Lamoliatte et al. 2014; Hendriks et al. 2015a; Hendriks et al. 2015b; Xiao et al. 2015). 
Identification of differential SUMOylation of hZCCHC7 by immunoprecipitation in nuclear and 
cytoplasmic fractions, as well as mutation of putative SUMOylation sites in the protein, would help 
identify whether these changes are necessary for virus-induced export. Additionally, mutation of 
the SUMO ligases and deSUMOylating enzymes may perturb hZCCHC7 localization and reveal 
how this protein is exported. 
The second major area of potential future study is in the composition of the VICE complex. My 
studies focused on the proteins which were identified in antiviral roles in Drosophila, namely Mtr4 
and Zcchc7, and confirmed that these proteins are antiviral in humans and form a virus-induced 
cytoplasmic complex. I was also able to demonstrate that hZCCHC8, which also interacts with 
hMTR4 in the nucleus as part of the NEXT complex, is not exported during viral infection, 
suggesting some specificity to TRAMP component export. However, I did not study the third 
TRAMP component, the poly(A) polymerase Trf4 (hTRF4-1 and hTRF4-2 in humans), as dTrf4-1 
was not antiviral and I found no evidence of adenylation of RVFV RNAs by 3’ RACE. However, 
whether this protein is exported during viral infection or not remains an open question, and would 
help to determine whether VICE shares the composition of TRAMP or is in fact a compositionally-
distinct TRAMP-like complex. Though target RNAs of TRAMP are generally known to be 
adenylated by Trf4, this adenylation is not essential for degradation of every target. Furthermore, 
despite the dispensability of dTrf4-1 in Drosophila, it is possible that hTRF4-1 or hTRF4-2 does 
restrict virus infection in human cells. 
The TRAMP-like complex NEXT, which shares hMTR4 with TRAMP but has otherwise different 
composition, was discovered by performing mass spectrometry on immunoprecipitated hMTR4 to 
identify binding partners (Lubas et al. 2011). By performing a similar experiment on cytoplasmic 
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hMTR4 during virus infection, I could identify additional binding partners of hMTR4 and hZCCHC7 
that might be involved in restriction of viral infection. If the VICE complex has different 
composition than TRAMP, it could involve other proteins not seen in the canonical TRAMP 
complex. Lysates from nuclear and cytoplasmic fractions, as well as from infected and uninfected 
cells, would help determine binding partners which are specific to the cytoplasmic compartment 
and to viral infection. 
The final area in which there are major unanswered questions is in the RNA motifs which are 
bound by TRAMP components and recruit the exosome for degradation. One way to identify 
these specific motifs would be with CLIP-seq analysis of hMTR4 or hZCCHC7. Though 
immunoprecipitation analysis of these proteins has been performed in many organisms and CLIP-
seq approaches have been performed in yeast, no study has yet explored the full complement of 
RNAs bound by the human TRAMP components (Schneider et al. 2012; Tuck and Tollervey 
2013). Performing such a study in both infected and uninfected cells could elucidate the full range 
of RNAs targeted by TRAMP as well as the cytoplasmic counterpart, VICE. This analysis would 
provide a key piece of information about human TRAMP, which does not target most of the RNAs 
targeted by yeast TRAMP, leaving its function in cellular homeostasis largely unknown (Lubas et 
al. 2011). Additionally, performing CLIP-seq in viral infection could identify the specific viral 
sequences bound by VICE, broadening our understanding of how viral RNAs are targeted. 
More specific methods could also be used to address this question. The genome of SINV is 
amenable to insertion of various RNA sequences, which we have previously used to test 
sequences for DDX17 binding (Moy et al. 2014a). Similarly, candidate RNA sequences could be 
inserted into or removed from the SINV genome and RNA immunoprecipitation performed to 
assess the effects on hZCCHC7 binding levels. The GFP 3’ UTR reporter which I used is another 
key tool; we can remove areas of the RVFV 3’ UTR from the GFP reporter, or clone in other 
bunyaviral and other 3’ UTRs, in order to identify the minimal sequence necessary for control by 
the exosome during viral infection. 
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In conclusion, I have used RNAi screening in a Drosophila model system to discover a broad and 
conserved antiviral role for both the RNA exosome and its cofactors. I have mechanistically 
explored how components of the TRAMP complex move to the cytoplasm in response to viral 
RNA, colocalize with other RNP granules, bind to the exosome and viral mRNA, and target this 
RNA for degradation based on sequences in the viral 3’ UTR. Furthermore, I have demonstrated 
the first cytoplasmic role for components of the TRAMP complex and characterized a new way in 
which exosomal targeting is regulated by cofactor relocalization. These studies have highlighted 
the role of RNA decay and targeting in antiviral defense, and provided a better understanding of 
the convergent pathways that respond to a variety of viral threats with a common downstream 
response. A more complete understanding of both RNA regulation and antiviral defense will 
enable new treatments for viral infections and a more thorough understanding of the interaction 
between disease and immunity at the level of RNA. 
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